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Cha
apter 1. In
ntroductio
on - Inhaleed deliveryy of siRNA
A
Maha Elssayed1, Olivia M. Merkeel1, 2
1

Departm
ment of Pharrmaceutical Sciences, 2Department of Oncologgy, Wayne State Univeersity,

Detroit, MI
M 48201
1.1.

Abstract
A
Inh
haled deliverry of siRNA
A using non-v
viral vectorss is a promissing tool forr the treatmeent of

diseases associated with
w overexpressed gen
nes, howeverr many barrriers exist inn the lung w
which
b overcomee. In this chaapter, we disscuss variouss types of siiRNA carrieers and succeessful
need to be
delivery systems for pulmonary delivery in vivo. A few
w clinical triaals targetingg the lung exxist at
the preseent time. Th
herapeutic applications
a
are developping by idenntifying new
w target gennes in
various lu
ung diseasess.
1.2.

siiRNA deliveery
RN
NA interfereence (RNAii) is a seq
quence-speciific post-traanscriptionall gene silenncing

mechanissm that occcurs naturallly in the ceell to disruppt double sttranded RN
NA (dsRNA)) and
regulate RNA expresssion. RNAii has been artificially
a
uttilized in thee past two ddecades to siilence
the expreession of disease-associaated genes an
nd hence haas been appliied in many versatile areeas of
research. RNAi hollds the mosst promise for the treaatment of ddiseases thaat are causeed by
overprod
duction of ceertain genes or expression of mutatted genes suuch as canceer [1]. RNAii was
first discovered by Fire
F and Melllo in C.eleg
gans worms in 1998 [2] for which tthe two scieentists
received the Nobel Prize
P
in Phy
ysiology and
d Medicine in 2006. Inn 2001, RNA
Ai was show
wn to

2
knock down target genes in mammalian cells without triggering immune responses; [3] which
was a very favorable outcome. RNAi can be artificially achieved in three ways: (i) Introducing
plasmid DNA to the cell that encodes for short hairpin RNA (shRNA) which is cleaved to short
(21-26 nucleotides) interfering RNA (siRNA) in the cell by the enzyme complex Dicer which
contains endoribonuclease activity. The resulting siRNA will lead to the cleavage and
degradation of the target mRNA. (ii) Introducing long double stranded RNA (dsRNA) which is
endogenously processed inside the cell by Dicer to siRNA. (iii) Directly introducing synthetic
siRNA to achieve mRNA degradation. The latter approach is of great interest and will be further
discussed in this chapter. When siRNA is internalized in the cell, the double stranded siRNA
binds to the RNA-induced silencing complex (RISC) and is unwound into two single strands; the
sense and anti-sense strand. The sense strand is removed and degraded by nucleases. The antisense strand directs the RISC to the complementary sequence of the mRNA to induce cleavage
by a catalytic component, Argonaute, and to post-transcriptionally silence the gene as shown in
Figure 1.1.
siRNA delivery: Introducing short interfering RNA
(siRNA, 21-26 nucleotides) with a specific sequence to the
cell in order to induce RNA interferenace (RNAi), and to
silence a specific target gene. siRNA delivery is used to
silence overexpressed genes in various diseases including
lung diseases.

3

Figure 1..1. Schematiic representaation of RNA
A interferencce (RNAi) m
mechanism. A
Adapted from
m [4]
with perm
mission from
m copyright holder.
h
1.3.

siiRNA deliveery to the lu
ung
Thee lung is prrone to man
ny diseases because of its physioloogical functiion, locationn and

exposuree to various pollutants which may cause diseaases such aas influenza,, asthma or fatal
diseases such as tuberculosis thaat are transm
mitted by airrborne pathoogens [5, 6]. As a resullt, the
lung has received speecial attentio
on as a targeet for siRNA
A-based theraapy. The anaatomy of thee lung
is divided into two different
d
zon
nes; first, thee conductingg zone i.e. m
mouth, nasall cavity, phaarynx,
nchi, and bro
onchioles wh
hich are respponsible for air conductiion and transsport.
larynx, trrachea, bron

4
The second zone is the respiratory zone where the gas exchange occurs. It consists of the
respiratory bronchioles and alveoli [7]. Pulmonary delivery of siRNA presents many advantages
compared to the systemic route such as the localized effect on lung epithelial cells with lower
administered doses of siRNA, reduced undesired systemic effects, and higher stability due to
negligible nuclease activity in the lung compared to the blood stream. In addition, the lungs can
function as a remarkable site of absorption for systemic effects with a rapid and effective
delivery due to the large alveolar surface area with high vascularization and thin air-bloodbarrier.

Such advantages have promoted pulmonary delivery to be an attractive route of

administration. However, pulmonary delivery also needs to overcome the barriers associated
with many parts of the respiratory airways. Coughing and dissolution are important parts of the
lung's defense against inhaled particles but can prove to be difficult barriers to overcome. The
ciliated epithelial cells in the lung perform a rapid mucociliary clearance action to remove any
deposited particles which are eventually swallowed or coughed out. The presence of the mucus
layer and surfactant proteins is another barrier for uptake. In addition, macrophages present in
the respiratory airways tend to phagocytose particles between 1 and 3 μm in size and to degrade
them. Therefore, the lung possesses several anatomical, physiological, and physiochemical
barriers that can be impaired or more prominent in a disease state and alter the efficiency of the
delivered agent to the lung [8, 9].
Mucociliary clearance: a host defense clearing
mechanism of the airways which is performed
by coordinated cilia movement to clear particles
deposited in mucus covering the respiratory
epithelium.
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For efficient siRNA delivery, a therapeutic agent is required to overcome those barriers
and successfully reach the lower respiratory tract where the cell layer and the mucus layer are
significantly thinner than in the upper airways. The site of the particle deposition in the lung
depends on the size, expressed as aerodynamic diameter, of the administered particle as well as
the patient’s pulmonary function [10-12]. Large particles with aerodynamic diameters larger than
6 μm are usually deposited at the back of the pharynx or throat due to their high momentum.
Thus, they are not suitable for the delivery to lower respiratory sites. Therefore, smaller droplet
or particle sizes are required to maximize the siRNA deposition in the lung. However, particles
smaller than 1 μm in aerodynamic diameter were believed to be exhaled during normal breathing
as their movement is controlled by Brownian motion [10-12]. For efficient deposition in the
lung, the optimal hydrodynamic diameter has been reported to range between 1 and 5 μm. Newer
studies show that as the size of the particles decreases below 100nm, the diffusional mobility of
the particles increases and hence their deposition in the lung increases. Nanoparticles (<100nm)
can successfully reach and settle in the alveolar site with 55 % and higher fractional deposition
depending on the particle diameter [13] and pulmonary function in healthy and asthmatic
subjects [14, 15].
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1.4.

Routes
R
of ad
dministration for pulmo
onary siRNA
A delivery
Sev
veral ways are used to administer siRNA to llung. Inhalaation is the easiest and most

common method useed; where siR
RNA can be formulated in a liquid fformulation ((aerosol) or a dry
powder aerosol.
a
Currrently availlable inhalattion devicess which can be used for inhaled siiRNA
delivery with some adjustment
a
an
nd optimizattion include nebulizers, metered dosse inhalers (M
MDI)
p
inhaalers (DPIs) [16, 17]. Allthough inhaaled adminisstration is cllinically the most
and dry powder
common method useed, very limiited studies chose the rooute of inhaalation for siiRNA deliveery in
m
Thiss disparity may
m be duee to the diffficulty of prreserving thhe biological and
animal models.
physicochemical stab
bility of siR
RNA in inhaalers. In ordder to preserrve the propperties of siiRNA
during th
he inhalation
n process, paarticles can be
b spray-driied and inhaaled in a dryy-powder aerrosol.
ExcellairrTM (ZaBeCo
or, Bala Cyn
nwyd, PA, USA),
U
is an inhaled siRN
RNA-based trreatment thaat has
entered phase
p
II of clinical
c
trialls for treatm
ment of asthm
ma. The intrranasal routee is another noninvasive and easily accessible route
r
of adm
ministration in which siiRNA is adm
ministered tto the
airways as a nasal suspension
s
in
i the nasal cavity. It iss simple annd adaptable; however, some
amount of
o the admin
nistered siR
RNA can be wasted in tthe nasal caavity or swaallowed [18,, 19].
siRNA-b
based clinicaal trials inclu
ude the succeessful study of ALN-RSV01 for resppiratory synccytial
virus (RS
SV) treatmen
nt which is currently
c
in Phase
P
IIb. T
The third adm
ministration route is the intratracheal one,
o which is
i more invaasive than the others. Thhus, it is onlyy employed in animal sttudies
and has not
n been utiilized in clin
nical trials. By
B far, mostt animal in vivo studiess use either intratracheal or intra-nassal administrration. The advantage oof the intrattracheal rouute, howeverr, can
ensure more
m
quantitaative delivery
y of siRNA to
t the lung aat reduced risk of swalloowing the dose.
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1.5.

In
ntracellularr barriers to
o pulmonary
y siRNA dellivery
Do
ouble strandss of siRNA are hydroph
hilic, negatiively chargeed macromoolecules. Thee cell

membran
ne on the oth
her hand is hydrophobic and negatiively chargeed which caauses electroostatic
repulsion
n of siRNA
A molecules. Due to th
his electrosttatic repulsiion, siRNA is incapabble of
crossing the cell membrane on its
i own in order
o
to reacch its target site [20]. T
Therefore, siiRNA
a used to facilitate
f
celll uptake [20
0, 21]. Interrnalization oof siRNA deelivery system
ms is
carriers are
mainly mediated
m
via endocytosiss [22]. Particcles intendedd for deliverry should be smaller thann 150
nm in sizze in order to
t be endocy
ytosed and to
t avoid maacrophage phhagocytosis [23]. Amonng the
many endocytotic paathways, claathrin-mediatted endocytoosis is the bbest characteerized pathw
way in
P
are bounded in
n clathrin-cooated vesiclles and trannsported to early
mammalian cells. Particles
endosom
mes which fu
use with latee endosomess and finallyy into lysosoomes where the pH graddually
drops to 5. At thiss low pH, nuclease
n
en
nzymes are present whhich rapidly degrade siiRNA
i desired thhat the nanoccarrier escapes the endossomal
moleculees. From a deesigning perrspective, it is
traffickin
ng to lysosom
mes and is released
r
from
m the endosoomes to the cytosol to pprotect the siiRNA
from enzzymatic deg
gradation. On
ne strategy to escape eendosomal ddegradation is to exploiit the
“proton sponge
s
effecct” that emplloys a polym
mer with higgh buffering capacity. D
During ripening of
an endossome to a lysosome,
l
th
he polymer can thus buuffer the pH
H by being protonated.. The
buffering
g of the pH leads to an increased in
nflux of prottons and chloride counteer ions. Thiss also
provides an osmotic influx of water
w
into th
he endosomees and subseequently leaads to endossomal
a release of
o siRNA intto the cytoso
ol [24]. Anotther strategyy is to use fuusogenic pepptides
rupture and
such as INF7
I
[25], GALA
G
[26], and KALA [27, 28] witth pH-depenndant structuures . At low
w pH,

8
such pep
ptides experrience a strructural con
nformationaal change thhat disruptss the endossomal
membran
ne and enablles the releasse of the siRN
NA [29, 30].
1.6.

siiRNA carrieers for pulm
monary deliv
very
Ov
ver the last years, reseearchers dev
veloped maany successsful formulaations of siiRNA

delivery that aim to overcomee the deliveery challengges describeed above. A
An ideal siiRNA
ocompatible,, biodegradaable, efficiennt at condennsing siRNA
A and
formulatiion is desireed to be bio
able to avoid
a
clearaance by maccrophages [3
31]. Once ddelivered to the cell surrface, the siiRNA
carrier sh
hould facilittate the inteernalization and cellulaar uptake innto the cell. Afterwardss, the
carrier sh
hould escapee the endosom
me and releaase the siRN
NA to the cyttoplasm, whhere the mRN
NA is
cleaved after
a
binding
g to the anttisense stran
nd in the acttivated RISC
C [32, 33]. Carriers aree also
desired to have miniimal toxicity
y and off-tarrget effects. In order to aachieve all tthese param
meters,
researcheers optimize siRNA carrriers in term
ms of the sizze, chemistryy, surface chharge, shapee, and
biocompatibility. In addition, it is necessary
y that the siR
RNA carrierr would be w
well-incorpoorated
patible with
h the excipieents of an aeerosol formuulation, i.e. propellants or lyoprotecctants
and comp
[34, 35]. During further formulattion, the siR
RNA integrityy and stabiliity needs to be maintainned so
that it maay be protectted from deg
gradation and
d the forces generated by aerosolizaation.
Off-target efffects are non-specific
n
c responsess
w
siRNA interacts witth RISC andd
which arise when
ntended targ
get genes resulting
r
inn
sillence un-in
measurable
m
ph
henotypes and
a unwanteed toxicities..
It is essentiaal to underrstand the mechanism
m
beehind the offf-target effecct to minimaalize it.
Tw
wo main app
proaches hav
ve been deveeloped for ddelivery of ssiRNA. The first approaach is
the chem
mical modificcation of nak
ked siRNA at
a the sugar,, at the ribosse backbone or at the baase of

9
the oligoribonucleotides which is pursued mainly to increase the nuclease resistance. In addition,
chemical modification of siRNA is aimed to increase siRNA specificity and potency as well as to
reduce the off-targeting and immune response without impairing the ability of siRNA to knock
down the target gene [36, 37]. Chemically modified siRNA therapeutics succeeded in clinical
trials. One example is Alynam's ALN-RSV-01 siRNA which is modified by cholesterol
attachment to the sense strand. The second approach may also employ modified siRNA but
additionally enhances the siRNA protection by using carrier systems which are divided into viral
vectors and non-viral vectors. Viral vectors take advantage of the penetration ability of viruses
through cellular membranes. Examples for viral vectors are retroviruses, adenoviruses, and
lentiviruses which can transfect cells very effectively. However, they present some safety
concerns such as toxicity, immunogenicity, tumorigenicity as well as uncontrolled virus
replication [38]. Despite their toxicity, viral vectors are still considered in clinical trials due to
their high transfection efficacy. In order to overcome these side effects, however, non-viral
vectors have gained great interest. They are subdivided into:
Non-viral
vectors
possess
low
host
immunogenicity, however lower transfection
efficiency compared to viruses. Various
strategies are followed to design and develop
non-viral vectors with enhanced transfection
efficiency.
i.

Lipid-based delivery vectors, such as liposomes and lipid particles. Positively-charged

lipids, for example, can interact with negatively charged siRNA oligonucleotides by
spontaneous electrostatic interaction to form lipoplexes. When aerosolized, lipoplexes may
underdo structural changes that may lead to premature release of siRNA from the lipoplexes
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[20, 39]. The drawbacks of these vectors are their toxicity and non-selective activation of
immune response [40, 41]. Many of the commercially available siRNA transfection agents
that are engaged in pulmonary delivery are lipid-based, such as lipofectamine® and
oligofectamineTM.
ii.

Polymer-based delivery vectors, such as synthetic poly (lactic-co-glycolic acid) (PLGA),

polyethylenimine (PEI), and natural chitosan. This class of vectors can easily be chemically
modified to avoid the induction of immune responses. In addition polymer-based vectors are
generally cheap, versatile and easy to modify to gain desirable characteristics such as
biodegradability and cell- specific targeting effect [42-44]. Polymeric vectors can be further
subdivided into polycations for electrostatic self-assembly and polymeric solid nanoparticles
which encapsulate their load. Polycations react with negatively charged siRNA to form
polyelectrolyte complexes, so called polyplexes. The main concern with polycations is their
toxicity generated from their charge. Examples for polycations widely used for siRNA
delivery are polyamide amine (PAMAM) dendrimers [45], PEI [24], and chitosan [46]. The
characteristics of the delivery system depend on the charge ratio, molecular weight of the
polymer and method of preparation [47]. Solid polymeric nanoparticles such as PLGA
nanoparticles encapsulate siRNA. The siRNA can be encapsulated and dispersed completely
in the nanoparticle core or surrounded by a polymeric shell.
iii. Peptide transduction domains (PTDs) or cell-penetrating peptides are small positively
charged molecules (10-30 amino acids). They usually contain arginine and lysine to provide
positive charges which electrostatically interact with siRNA and enhance the permeability of
the vector across the cell membrane.
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A summary of non-viral vectors used in pulmonary siRNA delivery in vivo is presented in Table
1.1.
Table 1.1: Examples of in vivo studies of siRNA delivery systems in the lung grouped according
to the type of delivery system
Type

of SiRNA/

Route

of Animal model

Delivery

Outcome

Re|22

siRNA

Targeted

administra

system/

22222

delivery

gene

tion

Polymer used

22222
22222
22222
22222

Naked siRNA

HO-1

Intra-nasal

C57BL/6 mice

Unmodified

Knock

siRNA

endogenous

down

of [48]
gene

expression

RSV-P

Intra-nasal

BALB/c mice

Unmodified

Inhibition of RSV infection

[49]

siRNA

SiRNA-

Intra-nasal

C57BL/6 mice

cy3

PAI-1

PAI-1

Intra-nasal

C57BL/6 mice

Intra-

Bleomycin-

tracheal

treated

Male

Unmodified

Low distribution of siRNA [50]

siRNA

in lung

Unmodified

Inhibition of PAI-1 level in [51]

siRNA

broncho-alveolar fluid

Naked siRNA

Inhibition of alveolitis and [52]
pulmonary fibrosis

12
Wistar rats

Fas
Caspase 8

Intra-

C57BL/6 mice

tracheal

Unmodified

Significant

reduction

siRNA

expression

of

Fas

in [53]
and

caspase 8 in lung

XCL1

Intra-

C57BL/6 mice

tracheal

Unmodified

Suppression

siRNA

mRNA

of

and

XCL1 [54]
protein

expression by 40-50%

KC-MIP-2

Intra-

C57BL/6 mice

tracheal

of

mRNA [55]

Unmodified

Suppression

siRNA

expression of KC and MIP2 in lung by ~40%
Reduction of IL-6 and
MPO activity

siSC2-5

Intra-nasal

Rhesus macaque

SARS [56]

Unmodified

Diminished

siRNA

coronavirus (SCV) levels
in monkey respiratory tract
Decreased

acute

diffuse

alveoli damage

EHV-1

Intra-nasal

BALB/c mice

Unmodified

significantly reduced viral [57]

siRNA

replication
signs

and

clinical
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Ang2

Intra-nasal

C57BL/6 mice

Naked siRNA

increases [58]

Ang2
inflammation

and

cell

death during hyperoxia

SiRNAcy3

Intra-

C57BL/6 mice

Modified siRNA

(2′O- tracheal

High

distribution

of [50]

siRNA- cy3 in lung

methyl

~21% knock down of E-

modificatio

cadherin but no significant

n)

reduction

of

endothelial

VE-cadherin

Lipid

RSV-P

Intra-nasal

BALB/c mice

Lipid (TransIT- Inhibition of RSV infection

[49]

TKO)

E-cadherin
VE-

Intra-

C57BL/6 mice

tracheal

cadherin

transfection [50]

Liposomes

Enhanced

(AtuFECT01/D

efficiency

PhyPE/DSPE-

siRNA compared to naked

PEG)

siRNA

of

lipoplex-

Lipoplex caused cellular
inflammation in lung

P38 MAP Intrakinase

tracheal

BALB/c mice

Lipid

Knock down effect not [59]

(cholesterol)

enhanced
Extended

duration

of

knock down compared to
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naked siRNA

SiGLO red

Intra-

nude mice with Liposomes

tracheal

orthotopic

(DOTAP)

model of human

Higher peak concentrations

[60]

Abundant longer retention
of liposomes in the lungs

lung cancer

compared with systemic
administration

SiGLO

Intra-

Green/SPA

tracheal

C57BL/6 mice

Lipid

SPARC siRNA significantl

(DharmaFECT)

y reduced gene and protein

RC

Polymer

WT1

[61]

expression

Intra-nasal

Mice

with PEI-WT1

Significant

B16F10

lung complexes

tumor foci

metastasis

Reduction

reduction

in

size

in [62]

and

number of tumor blood
vessels

EGFP

Intra-nasal

C57BL/6 mice

Chitosan

Effective (~37%) EGFP [63]
knock down in bronchiole
epithelial cells of mice

GAPDH

Intra-nasal

BALB/c mice
C57BL/6 mice

(~45) [64]

Imidazole-

Significant

modified chit-

knockdown

osan

enzyme in lung

of GAPDH
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Akt1

Inhalation-

K-rasLA1 mice

aerosol

Poly(ester

Inhibition of Akt-related [65]

amine)

signals and cell cycle
Significant suppression of
lung tumor progression

NS1

Intra-nasal

BALB/c mice

transfection [66]

Naonogene

Enhanced

NG042

efficiency

(chitosan)

high MW chitosan

compared

to

Attenuate RSV infection

EGFP

Intra-

C57BL/6 mice

tracheal

PEI

and

PEG

PEI- PEI-PEG

formulations [67]

caused ~42 knock down
efficiency

Luc

Dry

mouse lung met

powder

astasis model

Chitosan

Specific

gene

silencing [68]

effect against tumor cells

Inhalation

Peptide

P38 MAP Intrakinase

BALB/c mice

tracheal

*CPP (TAT and No increase in gene knock [59]2
penetratin)

down effect compared to
naked
provoked
reaction

2
*2CPP: Cell Penetrating Peptide and MW: Molecular weight

siRNA

and

inflammatory
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Schematic illustrations of non-viral siRNA carriers are illustrated in Figure 1.2. As discussed
later, nanocarriers can be chemically modified in a modular fashion to design multi-functional
particles which unite therapeutic and diagnostic properties that are target specific.

Figure 1.2: Schematic illustration of three classes of siRNA delivery systems; Polymer-, lipid-,
or dendrimer-based vectors form complexes with negatively charged siRNA via electrostatic
interaction. siRNA can be encapsulated in the core of the particle or attached to the particle
surface. Multi-functional nanocarriers can be engineered with multiple components to unite
multiple functions and to optimize siRNA delivery. Reproduced from [69] with permission from
copyright holder.
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1.7.

Targeted
T
pullmonary siR
RNA deliverry
2Taargeted siRN
RNA deliverry aims to reach the ttarget cell ttypes while minimizingg the

potential side effectss on non-targ
geted cell po
opulations. T
Targeted siR
RNA deliveryy via cell suurface
receptorss is achieved
d by receptorr-mediated endocytosis
e
[70]. For exxample, the ooverexpressiion of
transferriin receptors on a majoriity of cancerr cells rendeers the recepptor a good target for siiRNA
delivery [71]. In the
t
lung, active
a
targeeted deliverry can impprove the distribution and
pharmcok
kinetics of siRNA
s
by en
ngineering th
he surface oof the nanocaarrier with taargeting mooieties
that havee high affiniity to their identified recceptors and consequentlly enhance tthe uptake oof the
targeted delivery sysstems [72]. Furthermoree, targeted nnanocarrierss can be com
mplemented with
u
for deetection of tthe targeted tissue conccurrently, teermed
imaging probes whiich can be used
“theragno
ostics” [69].. By combin
ning multiplee functions iin one carrieer, so-calledd multi-functtional
nanocarriers can be obtained,
o
as shown in Fig
gure 2.
1.8.

Therapeutic
T
ns
application
Thee major advances in the pulmonary delivery of siRNA leadding towardss clinical research

hold a grreat potentiaal for treating
g many lung
g diseases. ssiRNA delivvery to the luung started iin the
early 200
00s addressing three lu
ung diseasess: severe ac ute respiratoory syndrom
me (SARS) [73],
respiratorry syncytiaal virus (RS
SV) [66, 74], and inffluenza [75]. Subsequeently, this work
expanded
d, and additiional endogeenous targett genes in puulmonary fibbrosis [51], lung cancerr [7679], asth
hma [80-82], tuberculosiis [6, 54], an
nd acute lunng injury (A
ALI) [53, 83]] were identtified.
Given the growing number
n
of stu
udies propossing siRNA delivery sysstems, identifying new ttarget
wn targets will
w prove to be invaluabble in diseaase treatmennt and
genes beesides the allready know
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prevention. Discovering these new target genes will eventually open new opportunities for
therapeutic siRNA delivery strategies. Pulmonary siRNA-based therapeutics are heading towards
fulfilling therapeutic effects in the lung by exploiting smart delivery systems. The development
of these systems requires a critical understanding of the numerous pulmonary barriers and
stringent optimization of the carriers in order to achieve maximum results.
Despite being a new field, reports on siRNA delivery in the literature increase steadily.
Therapeutics based on siRNA technology have entered clinical trials. Their success in terms of
safety and efficacy is currently being investigated at different stages. Many trials exploit local
delivery, including inhaled or intranasally delivered siRNA (Table 1.2).
Table 1.2: Examples of current siRNA-based clinical trials [84]
SiRNA

Delivery

Route of

Delivery

agent

administration

Naked

Intranasal spray

Sponsor

Disease

Status

Alnylam

*RSV infection

Phase

agent

ALN-RSV01

siRNA
ExcellairTM

unknown

Pharmaceuticals
Inhalation

ZaBeCor

II
Asthma

Pharmaceuticals
TKM-ApoB

Lipid

IV

nanoparticles
CALAA-01

Cyclodextrin

IV

Tekmira

Phase
II

Hypercholesterol Phase I

Pharmaceuticals

mia

Calando

Solid tumors

Phase I

19
nanoparticles

TD101

QPI-1007

Pharmaceuticals

Naked

Intradermal

Pachyonychia

Pachyonychia

Phase

siRNA

Injection

Congenita Project

congenita

Ib

Naked

IVT

Quark

Chronic optic

Phase I

Pharmaceuticals

nerve atrophy

Quark

AMD and

Phase

Pharmaceuticals

diabetic macular

II

siRNA

PF-655

Naked

IVT

siRNA

edema
AGN-745

Naked

IVT

Allergan

AMD

siRNA
QPI-1002

Naked

II
IV

siRNA

Bevasiranib

Naked
siRNA

Phase

IVT

Quark

Acute Kidney

Phase

Pharmaceuticals

injury

II

Opko Health

AMD

Phase
III

*RSV: Respiratory syncytial virus; IV: Intravenous injection; IVT: Intravitreal injection; AMD:
Age-related degeneration.
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1.9.
•

Summary
Pulmonary siRNA deliveery is a poweerful tool to ssilence any ttarget gene, thus, it can bbe

used for
f treatmentt of diseases associated with
w over exxpression of genes.
•

Pulmonary deelivery is asssociated with
h many advaantages, yet there are maany barriers that

challeenge successful delivery to the lung.
•

siiRNA is deliivered to thee lung by eith
her inhaled, intra-nasal oor intra-trachheal

admin
nistration.
•

siiRNA faces several intraacellular barrriers in orderr to reach thhe target site of action.

•

Non-viral
N
dellivery of siRN
RNA provides a wide varriety of optioons and oppoortunities.

•

Id
dentifying neew target genes, especiaally in cancerr, will open nnew potentiaals for siRNA
A

treatm
ments.
ments
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Chapteer 2. The influence
i
of oligospermine arrchitecturee on their suitabilityy for
siRN
NA deliverry
2.1.

Abstract
A

Speermines are naturally ab
bundant poly
yamines whi ch condensee and stabilizze helical nuucleic
acids. Th
hey can therrefore condeense DNA or RNA as nnon-viral vecctors for intrracellular nuucleic
acid deliivery. In th
his study, we synthesizeed bis- and tetrasperminnes with diffferent moleecular
architectu
ure to yield linear bissp
permine, lineear tetrasperrmine, and ddendritic tetrraspermine. Selfassembleed polyplex
xes of oligo
ospermines and siRNA
A were forrmed. The structure-acctivity
relationsh
hip of thesee carriers waas evaluated
d in terms o f their efficiency to delliver siRNA
A in a
non-smalll cell lung
g carcinomaa cell line (H1299/LUC
C). Oligosppermines dissplayed minnimal
cytotoxiccity but efficcient siRNA
A condensatiion capacityy with betterr stability aggainst polyannions
than poly
yethylenimin
ne at neutrall and acidic pH.
p The moorphology off the polypleexes was stroongly
affected by the oligo
ospermine arrchitecture. Linear tetraaspermine/siR
RNA polypllexes showeed the
best genee silencing efficiency
e
am
mong the oligosperminees tested on both the mR
RNA and prrotein
expressio
on levels. In conclusion,, the linear tetrasperminee had the moost favorable structure aand is
a promisiing siRNA delivery
d
vecttor.

2.2.

In
ntroduction
n
RN
NA interferen
nce (RNAi) is a post-traanscriptionall gene silenccing mechannism (PTGS) that

occurs naaturally in th
he cell in a sequence-sp
pecific mannner to break down double stranded RNA
(dsRNA)) and to reg
gulate RNA expression.1 RNAi-baseed therapeuutics have raapidly progressed

30
from basic research to clinical trials. In 1998, RNAi was discovered in C. elegans worms by Fire
and Mello, for which they received the Nobel Prize in Physiology and Medicine in 2006.2 Small
interfering RNA (siRNA) is an intermediate in the RNAi process and is double stranded RNA
with 21-25 nucleotides in length. Synthetic siRNA can be used to achieve RNAi and to downregulate overexpressed genes.3 In 2001, siRNA was reported to induce RNAi in mammalian
cells.4 To the present day, only a few human clinical trials for siRNA therapeutics are ongoing.
Among which, two therapeutics are targeting the lung, i.e. ALN-RSV01 and ExcellairTM.5
The primary challenge of siRNA therapeutics, however, is the hurdle of intracellular
delivery. siRNA cannot cross a biological membrane due to being a hydrophilic, negatively
charged macromolecule and highly prone to nuclease degradation.3b Viral vectors achieve high
transduction but are associated with many safety problems at the clinical level such as immune
responses and carcinogensis.6 Therefore, safe and effective non-viral siRNA carriers are required
for pulmonary delivery of siRNA.7
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on of oligosspermine/siR
RNA polypleex formation, cellular eentry,
Figure 2.1. Schemattic illustratio
endosom
mal escape, an
nd gene silen
ncing.
Cattionic poly
ymers interaact with negatively
n
ccharged oliigonucleoutiides via chharge
complexaation to fo
orm poly-eleectrolyte co
omplexes.8 Spermines (SPE) are safe, naturrallyoccurring
g, small lineear tetraamin
nes with two
o primary am
mines and tw
wo secondaryy amines thaat aid
to packag
ge cellular DNA
D
into a compact staate.9. The poolyamine strructure is reequired for sstable
DNA bin
nding. The in
nteraction beetween a sin
ngle cationicc amine and anionic phoosphate grouups of
nucleic acids
a
is relatively weeek and is further
fu
weakkened by coopetition off salt bindinng in
biologicaal conditionss.10 Exogeno
ous spermin
ne poorly coondenses and transfects nucleic aciids to
cells whiich could bee due to its low
l
molecullar weight (~
~200 Da).11 In addition, spermines yield
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limited endosomal escape despite their good proton-buffering capacity.11b It is hypothesized that
the maximum interaction of siRNA with cations consists of four carbon-bridges. However the
low molecular weight of spermine limits its siRNA complexation ability.12 Therefore, it was
necessary that spermine polyamines be modified to increase their molecular weight in order to
act as building blocks for nucleic acid delivery systems.11a,

13

This suggests that polymerized

spermines could be capable of condensing siRNA and of disassembling at the target site.14
Polyspermines showed high buffering capacity.15 Many studies described the linkage of
spermines through their amino groups by different cleavable linkers such as disulfide bonds or
esters.11a,

15-16

When polyspermines are degraded to release spermine monomers, sometimes

fragments of the linker are still attached to spermine monomers which affects their transfection
properties.17 Very recently, Du et al. compared three polymerized spermines to show that linkage
structures play an important role in the activity of the polyspermine-based nucleic acid carriers.8b
Moreover, spermine polymerization allows for multi-step intracellular degradation of a
biocompatible polymeric platform.14. Several groups have studied spermine-based carriers for
DNA,18

19 11a

siRNA,11a,

20

and short RNA delivery.21 Gene silencing efficiency was shown

specifically via aerosol delivery.21-22. Spermines have been incorporated in many delivery
systems such as lipoplexes,20b,

23

conjugates,20a and nanoparticles24 for siRNA delivery to

enhance the transfection efficiency. Vijayanathan et al. synthesized a series of spermine
homologues with different methylene chain length separating the secondary amino groups of the
polyamines. The lower homologues were more efficacious in DNA condensation than the higher
analogues. These results showed the importance of the regiochemical distribution of the positive
charge in the polyamines presented by the varying distance of the methylene spacing which
affected the polyamine ability to provoke structural changes in the DNA and hence strongly
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affected the DNA co
ondensation and size of DNA compplexes.25 Diffferent structtures of sperrmine
oligopoly
ymers were studied, fo
or example, when sperm
mine was uused as surfface groups of a
dendron structure to target humaan breast carrcinoma cellls (MDA-MB
B-231) and murine myooblast
cells (C2
2C12). Sperm
mine-decoraated dendron
ns were ablee to transfecct DNA to cells only in the
presence of chloroq
quine which
h enables the
t
endosom
mol escapee. Since blaank sperminne is
i is possiblee that these ddendritic struuctures havee only
completeely protonateed at physiollogical pH, it
a limited
d proton spo
onge effect. It was conccluded that dendritic sppermine deriivatives act more
similarly
y to polylysine and not liike proton sp
ponge polym
mers, such ass PAMAM oor PEI.11b
In this study, spermine
s
uniits were poly
ymerized too synthesize different chhemical strucctures
ospermines described as linear bissperminee, linear teetrasperminee and denndritic
of oligo
tetrasperm
mine. Thesee cationic po
olymers weree used to coondense siRN
NA moleculles in the forrm of
polyplexes (Figure 1).
1 Oligospeermine/siRN
NA polyplexxes were chaaracterized aand evaluateed as
or condensattion, stabilitty, transfectiion of siRN
NA and genne knockdow
wn in
non-virall carriers fo
H1299 human
h
non-ssmall cell lu
ung carcinoma cells. T
The aim of tthis study w
was to identtify a
suitable oligospermin
o
ne architectu
ure for siRNA
A delivery.
2.3.

Experimenta
E
al

2.3.1 Materials
M
Lin
near bissperrmine (MW 1299.40), linear
l
tetrasspermine (M
MW 2581.822), and denndritic
tetratsperrmine (MW 2625.87) weere synthesizzed as descrribed below. Lipofectam
mine 2000TM (LF),
SYBR® Gold dye, and (3-(4,5-dimethylthiiazol-2-yl)-22,5-diphenylltetrazolium bromide (M
MTT)
m Invitrogeen (Carlsbad
d, CA). Pollyethylenimiine (PEI, M
MW 5 kDa)) was
were purrchased from
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obtained from BASF (Lupasol®, Cologne, Germany). Dicer substrate double-stranded siRNA
(DsiRNA) targeting firefly luciferase gene (FLUC siRNA, 25/27mer), human glyceraldehyde 3phosphate dehydrogenase (hGAPDH) gene, nonspecific control (siNegCon) DsiRNA as well as
Alexa Fluor®-488 labeled siRNA were bought from Integrated DNA Technologies (IDT,
Coralville, Iowa). RPMI-1640 medium (1x) with 2.05 mM L-glutamine, HyClone™ trypsin,
penicillin/streptomycin, 4-(2(hydroxyethyl)-1-piperazine ethanesulfonic acid (HEPES), and
SurePrep™ TrueTotal™ RNA purification kits were purchased from Thermo Fisher Scientific
(Waltham, MA). Dulbecco's Phosphate Buffered Saline (PBS), Fetal Bovine Serum (FBS) Heat
Inactivated, D-(+)-Glucose, sodium bicarbonate, sodium pyruvate, 2-mercaptoethanol, dimethyl
sulfoxide Hybri-Max™ (DMSO, ≥99.7%), ethylenediaminetetraacetic acid (EDTA, 99.4%100.06%), trypan blue (0.4%, sterile filtered) and luciferin solution were bought from SigmaAldrich (St. Louis, MO). Hs_GAPDH_primers and Hs_β-actin-primers were purchased from
Qiagen (Valencia, CA). Brilliant III SYBR Green QRT-PCR Master Mix was bought from
Agilent (Santa Clara, CA). And DNAse I reaction buffer and DNase/RNase free water were
purchased from ZYMO RESEARCH (Irvine, CA).
2.3.2

Synthesis of Oligospermines
Three different polycatonic-based oligospermines namely, linear bisspermines, linear

tetraspermines and dendritic tetraspermines were successfully synthesized as described
previously.26 Briefly. the process involved 1) the synthesis of the monomer I MPBBSP
(monoprotected bis-boc spermine), 2) the synthesis of the reactive intermediates of 2-arm and 4arm linker, and 3) the conjugation of monomer I to the linkers to get respective protected
oligospermines. Deprotection of boc groups yielded oligospermines as salts of trifluroacetic acid
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that weree used for biological
b
ch
haracterizatiion. All com
mpounds synnthesized weere characteerized
using NM
MR, MS/MA
ALDI and HPLC
H
to confirm the iddentity and purity. Oliggospermines with
different structures were
w
screeneed to evaluatte their efficciency as siR
RNA deliverry carriers foor the
transfectiion of lung cancer
c
cells.

Figure 2..2. Schematiic representaation of oligo
ospermines ppolymers wiith different architecturees. A)
Sperminee B) Lineaar bisspermiines. C) Linear tetrasppermines. D
D) Dendriticc tetrasperm
mines.
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Sperminee is used ass the main building
b
blo
ock for the three polym
mers. SP= S
Spermine, BSP =
bissperm
mine.

Figure 2.3.
2 Chemicaal structuress of A) Lin
near bissperm
rmine, B) L
Linear tetrasppermine, annd C)
Dendriticc tetraspermiine.Prepara
ation of oligo
ospermines-siRNA pollyplexes
Thee ratio betweeen the poly
ymer amine groups
g
(N) aand the siRN
NA phosphatte groups (P
P) in a
polyplex is defined as
a the N/P ratio.
r
The N/P
N ratio obtaained after ccomplexatioon was calcuulated
based on
n the molecullar weight, number
n
of prrotonable unnits of the oliigosperminees, and numbber of
base pairrs in the siR
RNA duplex
xes. Polymeer stock soluutions (1 mgg/ml) were diluted withh 5%
glucose solution
s
and
d siRNA stocck solutionss (100 μM) w
were dilutedd with RNasse free-waterr. All
solutionss used were filtered witth 0.2 μm po
ore size syrringe filters (Fisher Scieentific, Walttham,
MA). Th
he amount of oligosperm
mines requirred to preparre polyplexees with a sppecific amouunt of
siRNA an
nd at a speciific N/P ratio
o was calculated as folloowing:
m(poly
ymer)= n(siR
RNA) X 52 X MW(proto
onable unit) X N/P

(11)
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Where m is the mass of the polymer needed, (n) is the amount of siRNA used per well. The
total number of nucleotides in DsiRNA is 52. N/P is the ratio between polymer amine groups and
siRNA phosphate groups.
Equal volumes of polymer and siRNA solutions were mixed to form the according N/P ratio,
vortexed for 30 s and incubated at room temperature for 20 minutes.
2.3.4

Size and zeta (ζ)-potential analysis
Sizes of polyplexes were evaluated by Dynamic Light Scattering (DLS) analysis.

Polyplexes were prepared with 40 pmol of FLUC siRNA at N/P 2 and 10 as described above in a
total volume of 350 μl. Measurements were performed with a Malvern Zetasizer Nano ZS
(Malvern Instruments Inc., Westborough, MA) in quadruplicates at 25 °C using disposable
cuvettes (low volume 70 μl, Brookhaven Instruments Corporation, NY, USA) for size
measurements. Measurements were set up at 173º backscatter angle with 15 runs per
measurement. For data analysis, the viscosity (0.88 mPa.s) and the refractive index (1.33) of
water at 25ºC were used. Results are given as Z average in nm +/- standard deviations.
Polyplexes were then diluted to 700 μl with 5% glucose solution before ζ-potential
measurements were performed in disposable capillary cells (Malvern Instruments Inc.,
Westborough, MA). Results are given in mV +/- standard deviations.
2.3.5

Size and Morphology: Transmission Electron Microscopy (TEM) and Atomic Force

Microscopy (AFM)
For Transmission Electron Microscopy (TEM), polyplexes were prepared as described
above at N/P 2 with 40 pmol of FLUC siRNA in a total volume of 20 μl. A drop of particle
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suspension was dispensed on a copper-coated grid (200-mesh) and left to dry before imaging
with a transmission electron microscope (JEOL 2010 TEM). Several representative images were
taken for each sample at different magnifications. Atomic force microscopy (AFM) was
performed using a Pico LE Atomic Force Microscope (Molecular Imaging, Agilent
Technologies, Santa Clara, CA). Polyplex suspensions were freshly prepared as described above.
A drop was incubated on a freshly cleaved mica surface for 5 minutes and rinsed with deionized
water to remove excess liquid. Samples were allowed to dry at room temperature and imaged in
contact mode using a Si3Ni4 V-shaped cantilever.
2.3.6

SiRNA condensation efficiency and stability against polyanions in neutral and

acidic conditions: SYBR® gold dye binding assays and heparin competition assays
SYBR® Gold assays were used to evaluate the capacity of the oligospermines to condense
siRNA at various N/P ratios (0 to 20). SYBR® Gold dye intercalates only with free and
accessible siRNA and does not fluoresce if the siRNA is condensed and protected by a
polycation. In a FluoroNunc™ 96-well white polystyrene plate (Nunc, Thermo Fisher Scientific,
Waltham, MA), 50 pmol of FLUC siRNA per well in 50 μl was complexed with the according
amount of oligospermine in the same volume to obtain the corresponding N/P ratios in a total
volume of 100 μl of 5% glucose solution. PEI (5 kDa) was used for comparison. Formulations
were incubated at room temperature for 20 minutes. A 4x SYBR® Gold solution (30 μl) was
added to each well and incubated in the dark for 10 minutes. Fluorescence was measured at 495
nm/537 nm excitation and emission wave lengths on a Synergy 2 Multi-Mode microplate reader
(BioTek Instruments, Winooski, VT). For heparin assays, polyplexes were prepared at N/P 2 as
described above. In addition, experiments were performed in presence of two different media to
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compare the stability of the polyplexes at different pH and ionic strengths. The media were 5%
glucose solution (pH 7.4) and sodium acetate buffer (pH 4.5). For the heparin assays, a master
solution of heparin was prepared (0.1 IU/μL). Serial dilutions of heparin were then prepared (0-1
IU/well) and added to the wells (10 μl/well). Subsequently, a 4x SYBR® Gold solution (30
μl/well) was added and incubated for 10 minutes. After different incubation times with heparin
(20 minutes, 1, 2 and 3 hours) at 25ºC, fluorescence was measured on a Synergy 2 Multi-Mode
microplate reader (BioTek Instruments, Winooski, VT) at 495 nm/537 nm excitation and
emission wave lengths. Measurements were performed in triplicates. The relative stability of
polyplexes was determined by normalizing the fluorescence intensity of the intercalating
SYBR® gold dye to SYBR® gold only (0%) and SYBR® gold with free siRNA (100%). Results
are shown as mean values +/- standard deviation and analyzed by Graph Pad Prism5.0 software
(GraphPad Software, La Jolla, USA).
2.3.7

Cell culture
NCI-H1299/LUC cells are derived from a human non-small cell lung carcinoma cell line

(ATCC®) and transfected to stably expressing the reporter gene luciferase.27 H1299/LUC
represents an established model for gene knock down studies as shown previously.27-28 Cells
were cultured and grown in RPMI-1640 cell culture medium (Thermo Scientific Hyclone,
Pittsburgh, PA) supplemented by sodium pyruvate (1 mM), HEPES (10 mM), 10% fetal bovine
serum (Thermo Scientific Hyclone, Pittsburgh, PA), and 1% penicillin/streptomycin. Cells were
grown in 75 cm2 cell culture flasks (Thermo Scientific, Waltham, MA) at 37 °C and 5% CO2 and
sub-cultured until approximately 90% confluence with changing fresh culture medium every 2-3
days.
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2.3.8

Cytotoxicity of polyplexes: MTT assay
H1299/LUC cells were seeded in a 96-well plate (Thermo Scientific, Waltham, MA) with

10,000 cells per well in 100 μl of growth medium and incubated for 24 hours at 37 °C and 5%
CO2 in a HERAcell 150i CO2 incubator (Thermo Scientific, Waltham, MA). Oligospermines
with varying concentrations (2-1000 μg/ml) were added to the cells in fresh media and incubated
for 24 hours at 37 °C and 5% CO2. Sterile filtered-MTT solution (5 mg/ml) was added to the
cells (10 μl/well) and incubated for 4 hours at 37 °C and 5% CO2. Water-soluble MTT is
enzymatically converted to insoluble formazan particles by metabolically active mitochondria.29
Subsequently, the cell culture media was removed, and DMSO (200 μl/well, Sigma-Aldrich, St.
Louis, MO) was added and incubated at room temperature for 10 minutes to solubilize the
formazan particles. The optical absorbance was measured at 540 nm on a Synergy 2 Multi-Mode
microplate reader (BioTek Instruments, Winooski, VT). The percentage of cell viability is
measured as the ratio between the absorbance of a sample and the untreated control cells. Results
are shown as the mean value +/- standard deviation of triplicates.
2.3.9

Quantification of cellular uptake by flow cytomtery
H1299/LUC cells were seeded in 24-well plate (Corning Incorporated, Corning, NY) with

a density of 200,000 cells per well and incubated for 24 hours at 37 °C and 5% CO2. Polyplexes
were freshly prepared as described above with 40 pmol of AlexaFluor488-labeled siRNA at N/P
ratio 2 and 10. Negative controls included untreated control cells. PEI (5 kDa) was used as a
positive control for comparison. Cells were transfected for 4 hours with 100 μl of cell culture
medium and 100 μl of polyplexes, after which growth medium was added to a total volume of
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500 μl, and cells were incubated for another 20 hours. Trypan blue quenching was used to
extinguish the extracellular fluorescence caused by polyplex binding and to confirm the
internalization of siRNA in the cells. Trypan blue 0.4% (100 μl per well), a dye that quenches the
extracellular fluorescence,30 was added to the samples for 5 minutes before trypsinizing the cells.
Results were compared to those obtained with cells that did not undergo trypan blue staining.
Cells were rinsed with 1X PBS buffer supplemented with 2 mM EDTA, treated with trypsin and
incubated at 37 °C and 5% CO2 for 3-4 minutes to detach the cells. Fresh medium (400 μl) was
added to each well to deactivate the trypsin. Samples were transferred to microcentrifuge tubes
(Seal-Rite, USA Scientific, Orlando, FL) and centrifuged at 400 g for 5 minutes. Samples were
washed twice with 1X PBS with 2 mM EDTA. Fluorescence was quantified by flow cytometry
on an LSR II (BD Biosciences, San Jose, CA) after staining with 4',6-diamidino-2-phenylindole
(DAPI) for dead cells. Cell fluorescence was measured with excitation at 488 nm and the
emission filter set to a 530/30 bandpass. Cell gating and data analysis was performed using
FACSDiVa™ (BD Biosciences, San Jose, CA) software. Measurements were performed in
triplicates; 10,000 viable cells each were gated and analyzed. Mean fluorescence intensity (MFI)
results are given as the mean value of three independent measurements. Data analysis was
performed by Graph Pad Prism5.0 software (GraphPad Software, La Jolla, CA).
2.3.10 RNA knockdown measured by qRT-PCR
In 6-well plates (Corning Incorporated, Corning, NY), H1299/LUC cells were seeded with
a density of 500,000 cells per well and incubated for 24 hours at 37 °C and 5% CO2. Polyplexes
were prepared with 200 pmol of hGAPDH siRNA at N/P 2 in a total volume of 100 μl and added
to 1 ml of cell culture medium per well. LF (0.5 μL/10 pmol of siRNA) was used as a positive
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transfection control. Cells were transfected with samples in fresh medium and incubated for 4
hours. After 4 hours of incubation, medium was added to a total volume of 3 ml, and cells were
allowed to incubate for an additional 20 hours. Subsequently, cells were washed with 1X PBS
and lysed with lysis buffer (SurePrep TrueTotal™ RNA Purification Kit (Fisher BioReagents,
Fisher Scientific, Waltham, MA). Total RNA was then isolated from cells according to the
manufacturer’s protocol with supplementary DNase I digestion and reverse transcribed to cDNA
and amplified in a one-step protocol using Brilliant III SYBR Green QRT-PCR Master Mix .
Hs_GAPDH-primers primers were used to quantify the gene expression of hGAPDH. Hs_βactin-primers were employed as a standard to evaluate the relative gene expression of the two
genes. Serial dilutions of total RNA of untreated cells were performed to plot calibration curves
for GAPDH and β-actin mRNA levels. Measurements were performed on a Stratagene Mx
3005P (Agilent Technologies, Santa Clara, CA). Ct values were analyzed with the MxPro
software (Mx 3005P version). Results were shown as mean values +/- standard deviation of
triplicates and analyzed by Graph Pad Prism5.0 software (GraphPad Software, La Jolla, CA).
2.3.11 Protein knockdown measured in reporter gene assays
H1299/LUC cells were seeded at a density of 25,000 cells per well in a 24-well plates
(Corning Incorporated, Corning, NY) and incubated at 37 °C and 5% CO2 for 24 hours before
transfection. Cells were transfected with polyplexes with 40 pmol FLUC siRNA or nonspecific
control DsiRNA at N/P 2 and allowed to incubate for 4 hours. Commercially available LF
2000™ was used as a positive control. After 4 hours of incubation, medium was added to a total
volume of 500 µl and allowed to incubate for an additional 44 hours. Cells were washed with 1X
PBS and lysed with cell culture lysis reagent (CCLR 1X, 100 μl/well, Promega, Fisher Scientific,
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centrifug
ged at 15,00
00 g for 5 minutes.
m
Lu
uciferase exp
xpression waas quantifiedd by mechaanical
injection of 50 μl lucciferase assaay buffer, co
ontaining 10 mM luciferrin, into eachh well contaaining
20 μL of
o cell lysatee using a Synergy
S
2 Multi-Mode
M
microplate reader (BiooTek Instrum
ments,
Winoosk
ki, VT). Relaative light un
nits (RLU) were
w
measurred as the meean value off gene expreession
relative to
t untreated cells with full
fu expressio
on (100%) +
+/- standard deviation off triplicates. Data
was statiistically anaalyzed using
g Graph Pad
d Prism5.0 ssoftware (G
GraphPad Sooftware, La Jolla,
CA).
2.4.

Results
R
and discussion
d

2.4.1

Synthesis of oligospermines
nomers were covalently
y coupled tto yield thrree differennt polymers with
Speermine mon

different amounts of spermine units and distinct
d
geom
metrical struuctures. Thee three polyymers
mine, linearr tetrasperm
mine, and ddendritic tettraspermine. The
tested heere are lineear bissperm
nomenclaature of the polymers was
w based on
n the structuure and num
mber of sperrmine monom
mers.
Oligospeermine polym
mers were ch
haracterized by NMR annd purified bby HPLC. M
Molecular weeights
of the po
olymers werre obtained by Mass Sp
pectrometry for linear bbissperminess (MW 12999.40),
linear tettrasperminess (MW 2581.82) and den
ndritic tetrattspermines ((MW 2625.887). The diffferent
architectu
ures of the oligospermin
o
nes were chosen to obtaain differencces in the chharge distribbution
over the different strructures. Ou
ur aim was to
t compare the siRNA polyplex forrmation of llinear
and dend
dritic structu
ures with diff
fferent cation
nic charge deensities. At neutral pH ((7.4) of the intraand extracellular en
nvironment, it is expeccted that onnly the prim
mary aminess are protonnated,

44
whereas only a small portion of the secondary amines are protonated.31 The linear tetraspermine
has the highest number of secondary amines compared to the other two oligospermines
suggesting the ability of this polymer to act as a “proton sponge” at the acidic pH of the endolysosomal compartment.32 The structure of linear tetraspermines possesses multiple spermine
units in a linear arrangement which enables cross-linking of single oligospermine molecules.
Cross-linked polymers have been reported to better interact with negatively charged regions of
nucleic acids and can therefore yield enhanced transfection efficiencies.33
Dendritic structures are also very attractive as gene and drug delivery systems since they can be
flexible structures with a multitude of end groups. The latter can be exploited to attach ligands,
which opens various opportunities for cell-specific targeting. Due to their structure, dendrimers
are believed to be more accessible for electrostatic interaction with RNA.34 In flexible
dendrimers, the amines located within the inner structure are accessible for protonation which
results in an increased “proton sponge effect”35 and consequently better transfection efficiency.34
2.4.2

Size and zeta (ζ)-potential analysis
To achieve efficient transfection, polyplexes must be well-characterized and reproducible.

Many of the physico-chemical properties of polyplexes determine if they can overcome
intracellular and extracellular barriers.36. Their size is an important factor for intracellular uptake
and transfection. Some reports indicated that particles with a size below 150 nm are required for
uptake in lung cells by endocytosis.37. However, other reports described that spermine-based
delivery systems with a larger size have good transfection efficiency in vivo and are suitable for
lung cancer gene therapy.21a The ability of oligospermines to condense siRNA and form
polyplexes with defined structures was therefore evaluated here. Polyplexes prepared with 40
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pmol of FLUC siRNA at N/P 2, 5, and 10 were compared in terms of hydrodynamic diameters
and zeta-potentials. The change of size and zeta potential of polyplexes as a function of
carrier/siRNA ratio was examined to determine a suitable N/P ratio for further investigations. All
three oligospermines were able to condense siRNA into particles of sizes from 198.7 to 423.1 nm
in diameter (Figure 2.4A). All polyplexes at N/P 5 were at least slightly larger than those at N/P
2, which is in line with an earlier report that described N/P ratio dependent trends in sizes of
siRNA polyplexes.38 Interestingly, both linear oligospermines showed an increase in size with
increasing N/P ratios. Apparently, these polymers wrapped around the siRNA efficiently at an
N/P ratio as low as 2 and then formed further layers of polymer on the surface of the polyplex.
Another indication that supports this hypothesis is the increase of the zeta potential for the linear
tetraspermine polyplexes with increasing N/P ratio (Figure 2.4B). Although linear
bisspermine/siRNA polyplexes did not show a significant change in the zeta potential when
increasing the N/P ratio, the zeta potentials of linear tetraspermine polyplexes increased from 1.5
mV to 10.6 mV and 12.7 mV for N/P 2, 5, and 10, respectively.
The dendritic tetraspermine, however formed polyplexes with decreased size at N/P 10
(225.4 in diameter nm and 17.6 mV). This behavior can be explained by its intertwining structure
that causes not all amines of the tetraspermine to be available for electrostatic interaction with
siRNA at low N/P ratios. The comparably high zeta potentials these polyplexes bear also support
the idea of positively charged dendrimer arms that are unable to be neutralized by the interaction
with phosphates.39 However, these relatively high zeta potentials could possibly mediate
cytotoxicity.40 Zeta potentials of dendritic tetraspermines polyplexes increased with increasing
N/P ratios. Comparing polyplexes of linear and dendritic tetraspermines, the zeta potential of the
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linear tetraspermine polyplexes were lower than that of the dendritic tetraspermine polyplexes at
all of the tested N/P ratios (2, 5 and 10, Figure 2.4B).
The surface charge of polyplexes is a significant factor for transfection efficiency of the
polymer. Other studies have shown the ability of spermine-based polymers to neutralize the
negative charge of nucleic acids to yield an overall neutralized to slightly positive charge suitable
for interaction with the negatively charged cell membrane.13 In our study, all oligospermines
polyplexes were positively charged (Figure 2.4B).
Another prerequisite for successful and reproducible transfection, especially in vivo, is a
narrow size distribution of the polyplexes 39. The polydispersity expressed as the polydispersity
index (PDI) was low for polyplexes formed with the linear bisspermine (0.14<PDI< 0.3)
compared to those formulated with the linear tetraspermine (0.26<PDI<0.34) and dendritic
tetraspermine (0.22 <PDI<0.36, Table SI 1). The broader size distribution of the polyplexes
obtained with the tetraspermines can be interpreted as a result of interaction between one longer
polycationic polymer with more than one siRNA molecule, which can cause coalescence of the
polyplexes.39 Many physical and biological parameters such as the molecular weight play an
important role in determining the efficiency of a polymer to condense and deliver siRNA,.41.
Linear tetraspermines (MW 2581.82) and dendritic tetraspermines (MW 2625.87) naturally have
a higher molecular weight compared to linear bisspermines (MW 1299.40), which affects the
ability of the polymers to interact with siRNA and to form polyplexes. As reflected by the size
and zeta potential data shown in Figure 2.4, the structure of the polymer also plays a very
important role regarding the ability of an oligospermine to interact electrostatically with siRNA.
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Based on these results, the linear tetraspermine/siRNA polyplexes seemed to be the most
favorable with the smallest size at N/P 2 (198.7± 22 nm) and a slightly positive zeta potential
(1.54 mV). These characteristics are caused by (i) a favorable number of positively charged
spermine units (4 units), and (ii) the linear structure which seems to be important for efficient
interaction with siRNA and to yield a low positive close to neutral surface charge that facilitates
the crossing of the particle across the negatively charged cell membrane barrier. Polyplexes at
N/P 2 with hydrodynamic diameters of 253.4± 26.3 nm for linear bisspermine polyplexes,
198.7± 22 nm for linear tetraspermine polyplexes, and 311.5±18.5 nm for dendritic tetraspermine
polyplexes were therefore selected for further experiments.
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2.4.3

Size and morphology: Transmission Electron Microscopy (TEM) and Atomic Force

Microscopy (AFM)
The morphologies and sizes of the different polyplexes at N/P 2 were imaged by AFM
(Figure 2.5). The sizes of the polyplexes estimated from the AFM images were 24-73 nm for
linear bisspermine polyplexes, 101-348 nm for linear tetraspermine polyplexes, and 202-480 nm
for polyplexes made with the dendritic tetraspermine. The differences between the sizes obtained
by DLS compared to the AFM images can be explained by the different processes used to
prepare the samples for DLS or AFM. The hydrodynamic diameters were determined in a
suspension of the particles while the particles were dried for AFM. It is possible that polyplexes
coalesced during the drying step. Additionally, the broad size distribution of the polyplexes
shown by the imaging technique and confirmed by the polydispersity measurements (PDI) can
explain why the Z average of the hydrodynamic diameters does not reflect the sizes measured by
AFM. Most importantly, AFM images showed different morphologies of oligospermines
polyplexes as a result of the different chemical architectures of the polymers used. Both linear
oligospermines formed spherical particles, while the dendritic tetraspermine complexes show
less defined morphology. These observations strengthen the hypothesis that linear
oligospermines wrap around siRNA and condense it efficiently, whereas not all arms of the
dendritic tetraspermine are involved in siRNA condensation, as shown in the fuzzy morphology
of the polyplexes.
TEM showed electron-dense areas in the polyplexes which could be the siRNA and the
presence of very small particles (about 40 nm) in all polyplex formulations besides larger
particles of 440 nm, 330 nm, and 189 nm for linear bisspermine, linear tetraspermine and
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reflected by increasing zeta potentials (Figure 1). With the rise of the zeta potential, the
electrostatic interaction is enhanced, followed by higher condensation. All oligospermines were
able to completely condense siRNA at N/P 2 and higher, whereas complete condensation of
siRNA was only achieved at N/P 5 and higher for low molecular weight PEI. These results
indicate that oligospermines tend to bind siRNA with higher affinity than PEI at low N/P ratios.
Noticeably, linear bisspermine/siRNA polyplexes at N/P 2 showed relatively low condensation
of siRNA compared to the other two oligospermines. This observation can be explained by the
low molecular weight and short chain length of the bisspermine compared to the tetraspermines.
The fact that the condensation efficiency did not increase for the bisspermine by increasing the
N/P ratio additionally corroborates the observation of almost constant zeta potentials. Polyplexes
with N/P 2 ratio were selected for further experiments based on their small size and overall good
siRNA condensation.
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against heparin competition, especially at low concentrations of heparin (Figure 4). It is
important to note that the release profile from low molecular weight PEI complexes needs to be
seen in the context of its poor condensation at N/P 2. As shown in Figure 3, at N/P 2, 75% of the
siRNA is not yet condensed by 5 kDa PEI. It is not surprising, therefore, that the same amount of
siRNA (75%) is found to be accessible for intercalation even in the absence of heparin. The
remaining 25% of the siRNA are consequently very easily released from the complexes as shown
in Figure 4.
At neutral pH, less than 75% of the siRNA was released from the oligospermine complexes
even at the highest heparin concentration (Figure 2.7A). Since a balance between complexation
and decomplexation is necessary to release siRNA in the cytosol for efficient incorporation to the
RNA induced silencing complex (RISC), the release profiles at lysosomal pH were tested also.
At acidic pH, many amines, especially in PEI, which are not protonated at pH 7.4, were charged
leading to an increase of the complexation efficiency. However, siRNA was easily released from
PEI complexes at comparably low heparin concentrations at acidic pH also. In comparison,
oligospermine complexes displayed better stability again. In the acidic environment, the
tetraspermine complexes released comparable amounts of siRNA as PEI at high heparin
concentrations. Only the bisspermine lacked efficient decomplexation properties.
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polyplexes made of linear spermines, however, results in more quantitative competition with
siRNA and thus release of the latter.
2.4.5

Polymer cytotoxicity: MTT assay
The formulation of non-viral vectors of cationic polymers and anionic nucleic acids is

constrained by the compromise of high transfection efficiency which is often times only
achieved at the price of high cytotoxicity.47 Using cationic polymers with high molecular weight
and charge density can protect the resulting polyplex from destabilization by natural cellular
polyanions. The trade off, however, is that these positive charges can interact with cell
membranes, inhibit crucial biological processes and lead to cytotoxic effects.
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MTT assays

were therefore used here to evaluate the cytotoxic effect of three cationic oligospermine
polymers on H1299/LUC cells after 24 hours of incubation with the polymers. Results are
presented as percentage of cell viability compared to untreated control cells. As expected, the
cytotoxicity of oligospermines increased with increasing polymer concentration. Moreover,
increasing the cationic charge of the polymer by increasing the number of spermine moieties also
increased the cytotoxicity. Linear tetraspermines and dendritic tetraspermines showed a higher
toxicity at higher concentrations when compared to linear bisspermines. This trend is due to the
presence of a higher number of positively charged groups at neutral pH in the linear
tetraspermine (13 positively charged groups) and dendritic tetraspermine (14 positively charged
groups) compared to linear bisspermine (7 positively charged groups). The dendritic
tetraspermine polymer was even more toxic than the linear tetraspermine at high concentrations
(0.5-1 mg/ml) which may be due to its structure. In conclusion, all oligospermines affected the
cell viability significantly less than PEI (5 kDa, IC50=3.63 µg/ml) and commercially available
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LF 2000TM (IC50=41.41 µg/ml). At the corresponding polymer concentrations in polyplexes
used in the following experiments, the cell viability was at least 83% after treatment with linear
bisspermine, 88% with linear tetraspermine, and 77.3% with dendritic tetraspermine (Figure 2.8).
It is important to note that the positive charge of the polymers is neutralized after polyplex
formation with siRNA, so the viability shown here after treatment with polymer only is the
assumption of a “worst case scenario”.
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Figure 2.8. Cytotoxicity profiles of oligospermine polymers obtained by MTT assays.
Percentages of cell viability of H1299/LUC cells are shown as a function of increasing polymer
concentration after 24 hours of polymer incubation. The table shows the IC50 concentrations of
the polymers in mg/ml.
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2.4.6

Quantification of cellular uptake by flow cytomtery
Cellular uptake was quantified by flow cytometry and compared to PEI (5 kDa) as a

positive control and untreated cells as a negative control. Polyplexes with 40 pmol of
AlexaFluor488-labeled siRNA at N/P 2 and 10 were compared. Additionally, trypan blue 0.4%
was used on the cells to quench the extracellular fluorescence associated with polyplexes that
bind to the surface but are not internalized. The results were compared to untreated cells.
Overall, trypan blue-treated cells showed slightly lower mean fluorescence intensities compared
to cells that did not undergo quenching of bound polyplexes. This indicates that a small fraction
of the siRNA polyplexes were attached to the cell membrane but are not taken up intracellularly.
Among the oligospermine polyplexes, the highest cellular uptake was achieved by polyplexes
made of linear tetraspermine/AlexaFluor488-siRNA at N/P 2 (no trypan blue-treatment) (Figure
2.9). These results are surprising because linear tetraspermine polyplexes were almost neutral at
N/P 2 (1.54±0.5 mV), whereas dendritic tetraspermine polyplexes had a more cationic zeta
potential (12±0.85 mV). For polymers such as PEI, an increase of the zeta potential which is
obtained by increasing the N/P ratio is expected to mediate stronger siRNA delivery. This trend
was confirmed here. However, PEI polyplexes at high N/P ratios are known to cause toxicity and
off-target effects in transfected cells.48 While the siRNA delivery by oligospermine polyplexes
was comparable to PEI at N/P 2, an increase of the N/P ratio to 10 did not increase their
efficiency. Linear tetraspermine polyplexes at N/P 2 were found to have the smallest
hydrodynamic diameters, however. It is possible that this parameter is favorable for uptake and
crossing of the barrier of the cell membrane. Additionally, the spherical morphology of the linear

59
oligospermine complexes compared to the fuzzy morphology of the dendritic tetraspermine
polyplexes could have beneficially affected their internalization.
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Figure 2.9. Flow cytometry measurements showing the uptake of polyplexes made of
AlexaFluor-488 labeled siRNA and linear bisspermine, linear or dendritic tetraspermine. Mean
fluorescence intensities were quantified in H1299/LUC cells after 24 hours incubation with
polyplexes prepared at N/P 2 and 10. Trypan blue treatment is performed to quench the
extracellular binding of siRNA polyplexes to the cell. Cells treated with trypan blue showed
decreased mean fluorescence intensities.
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2.4.7

RNA knock down measured by qRT-PCR
Real-time PCR was performed to quantify the knock down on the mRNA level mediated

by polyplexes made of GADPH siRNA (200 pmol/well) and oligospermines at N/P 2. All
oligospermines were used to form polyplexes with negative control siRNA (siNC) also. Linear
bisspermine/siRNA polyplexes did not show gene silencing. This can be attributed to the
incomplete siRNA release from the polyplex in the endo-lysolomal compartment as shown in
Figure 4B. The most efficient oligospermine candidate was the linear tetraspermine, which is in
line with the results of polyplexes size, zeta potentials, and flow cytometry. Linear tetraspermine
polyplexes were shown to significantly downregulate the RNA expression more effectively than
dendritic tetraspermines (54.6±17.3% vs. 75.1±1.5% residual GAPDH expression) (Figure 2.10).
The dendritic structures showed less RNA knock down compared to the linear tetraspermine
structure which could be explained by its less efficient uptake into the cells. In addition, the lack
of secondary amines in the dendritic structure contributes to the lack of the “proton sponge
effect”.35 Comparing the results of the three oligospermine polyplex formulations, we conclude
that the difference in the architecture of the polymer strongly affected the efficiency of siRNA
delivery to H1299/LUC cells. The linear tetraspermine structure is favored for successful siRNA
delivery in lung cancer cells.
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Figure 2.10. Transfection efficiency in vitro (H1299/LUC cells) of polyplexes at N/P 2 on the
mRNA level measured by qRT-PCR. Hs_GAPDH-primers were used to quantify hGAPDH gene
expression. Hs_β-actin-primers were employed as a standard to evaluate the relative gene
expression of the two genes. Polyplexes made of GADPH siRNA and linear tetraspermine
showed the best knock down compared to dendritic tetraspermine (54.6% vs. 75.1% residual
GAPDH expression) and linear bisspermine polyplexes (no knock down).
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2.4.8

Protein knockdown measured in reporter gene assays
At pH 4.5, the secondary amines are protonated leading to a strong buffering capacity

inside the endosomes and thus a further influx of hydrochloric acid and water leading eventually
to endosomal rupture. This event is believed to release endocytosed polyplexes and to support
their endosomal escape into the cytosol.31 The silencing efficiency of the luciferase protein
expression in H1299/LUC cells induced by oligospermines polyplexes at N/P 2 was evaluated
after transfection with 40 pmol of anti-LUC siRNA after 48 hours of incubation. The results
were normalized to the relative expression of untreated cells and compared to commercially
available LF 2000™. LF was used in many studies as a positive control for siRNA mediated
knock down efficiency.49 As in the mRNA knock down experiments, negative control siRNA
(siNC) was also used with all oligospermines and LF. Linear tetraspermine/siRNA polyplexes
showed the best knock down effect of luciferase expression compared to the other 2
oligospermines (Figure 2.11), which is in agreement with the RT-PCR results. The dendritic
tetraspermine and LF showed higher cytotoxic effects than the other polymers which can be
explained by the cytotoxicity results shown in Figure 7. These results suggest that not only did
the oligospermine architecture affect the interaction of the protonated portions of the polymer
with the phosphate groups of siRNA, but these different siRNA complexation behaviors also
lead to different efficiency of gene knock down. Linear bisspermine polyplexes were taken up by
the cell but, showed neither knock down on the mRNA nor the protein level. This is attributed to
the lack of amines in the short chain length and low molecular weight of the bisspermine
structure which does not condense siRNA as quantitatively as the tetraspermines (Figure 2.3.)
and also does not efficiently decomplex (Figure 2.7). Our results are in line with other reports in
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which Eliyahu et al. compared two chemically-modified spermine-based delivery systems for
DNA delivery in terms of the number of spermine moieties and the distribution of charge density
on the polymer backbone. In their study, a low and a high sperminated polymer were examined.
The low sperminated polymer showed 56% less spermine per weight and 28% less primary
amines than the high sperminated polymer. The low sperminated polymer was less efficient in
neutralizing the negative groups of the nucleic acids and hence showed lower transfection
efficiency compared to the high sperminated polymer.31 Another study of cationic spermine
conjugates with different polysaccharides showed efficient in vitro transfection with high
spermine content (2000 nmol/mg).31

In vivo experiments showed that chemically-modified

dextran-spermine polyplexes successfully transfected mice with low toxicity and good
tolerability when combined intramuscular and intranasal administration was performed.33,
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However, for efficient transfection, high positive zeta potential of the polyplex and large DNA
doses were necessary.50 Dendritic structures have been described to be more accessible for
electrostatic interaction with RNA.34 This is the case if the structurally inner amines are available
for protonation which then also enhances the “proton sponge effect”,35 the endosomal escape,
and the transfection efficiency.34 However, our results showed that the amines in short dendritic
structure are not all available for interaction with siRNA. In comparison with short linear
structures, short dendrimers are more rigid. The protonated amines in the dendritic structure were
thus not neutralized which increased the cytotoxicity of the polyplexes. The polyplexes made
with the dendritic structure did not show strong uptake or gene knock down efficiency which
may be due to the larger sizes at N/P 2 compared to the other two polymers or the less spherical
morphology. Therefore, the structural architecture of dendritic tetraspermine was associated with
increased cytotoxicity and decreased transfection efficiency.
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Figure 2.11.
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decomplexation of siRNA and the carrier’s ability to escape the degradation in lysosomes are
two main factors in determining the polymer’s transfection efficiency. The spatial availability of
the positively charged amines in the polymer plays an important role for its electrostatic
interaction with RNA and thus the shielding and protecting of siRNA. Therefore, the
oligospermine architecture was shown to affect the transfection efficiency of polyplexes formed
with siRNA. Consequently, an optimization of the used polymer is necessary. This can be
achieved in many ways. Here, we investigated the effect of using different numbers of spermine
monomers. In addition, we examined the effect of two different geometrical structures, namely
linear and dendritic oligospermines. We found that tetramers of spermine are required to provide
the adequate positive charge for both uptake and buffering effect for endosomal escape. From the
comparison of linear bisspermines and linear tetraspermines, we found that increasing the
number of spermines and charge density within the polymer enhanced the transfection efficiency
at minimal toxicity. The linear structure is preferred over the dendritic structure, because the
former seems to interact more efficiently with siRNA as not all amines of the latter are available
for siRNA condensation leading to a more positively charged surface charge. Showing more
efficient charge neutralization, the linear tetraspermine polyplexes are less cytotoxic and were
shown to be more efficiently transfected into lung carcinoma cells (H1299/LUC). Therefore, we
conclude that linear tetraspermines are very promising siRNA delivery systems. To enhance their
intracellular uptake, coupling of targeting ligands is currently investigated.
Supplementary Information contains polydispersity values, TEM images, and the temporal
development of siRNA release at pH 4.5. This material is available free of charge via the
Internet at http://pubs.acs.org.
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Supplemento
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Table SI 2.1: Polydisspersity (PDII) values of oligospermi nes polyplexxes at differeent N/P ratioos
Polymer
P
used
d in polyplex
x
Linear
L
bisspeermine
Linear
L
tetrasp
permine
Dendritic
D
tetrraspermine

N/P raatio
2
5
10
2
5
10
2
5
10

P
PDI
00.301
00.293
00.141
00.26
00.29
00.34
00.36
00.35
00.22

S 1: TEM images
i
of polyplexes
p
at
a N/P 2 wiith the A) liinear bisspeermine, B) llinear
Figure SI
tetrasperm
mine, and th
he C) dendrritic tetraspeermine show
wing differennt morphologies and average
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sizes of 440
4 nm, 330
0 nm, and 18
89 nm respecctively. D) S
Small spheriical particless of size aboout 40
nm were confirmed by
b both TEM
M and AFM images in alll oligosperm
mine polypleexes.

pment of the stability pro
ofiles againsst heparin poolyanions forr polyplexess with
Figure SII 2. Develop
A) linearr bisspermin
ne, B) linear tetraspermin
ne, C) dendrritic tetraspeermine, and D) 5 kDa P
PEI at
pH 7.4 after
a
20 min
nutes, 1 hou
ur, 2 hours and 3 hourrs of incubaation of the polyplexes with
increasin
ng concentraations of hep
parin. All oligosperminee polyplexess showed a sslight increaase of
released siRNA overr time at pH 7.4.
At pH 7.4, lin
near bissperm
mine polyplexes showe d significannt increase iin siRNA reelease
(p<0.000
01) over timee compared to insignificcant increasees with otheer polymers (Figure SI 22). At
pH 4.5, polyplexess made witth the lineaar bissperm
mine and liinear tetrasppermine showed
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significan
ntly decreased siRNA release (p
p<0.0001) oover time w
which indiccates a dynnamic
rearrangeement of the polyplexes in presence of heparin. O
On the otherr hand, polypplexes madee with
the dend
dritic tetrasp
permine and
d PEI (5 kD
Da) showedd significanttly increasedd siRNA reelease
(p<0.000
01) over tim
me (Figure SI
S 3). Thesee results shhowed higheer stability of polyplexxes in
neutral medium
m
than in acidic meedium.

Figure SII 3. Develop
pment of the stability pro
ofiles againsst heparin poolyanions forr polyplexess with
A) linearr bisspermin
ne, B) linear tetraspermin
ne, C) dendrritic tetraspeermine, and D) 5 kDa P
PEI at
pH 4.5 after
a
20 min
nutes, 1 hou
ur, 2 hours and 3 hourrs of incubaation of the polyplexes with
increasin
ng concentraations of heparin.
h
Forr polyplexees with lineear bissperm
mine and llinear
tetrasperm
mine, the reelease of siR
RNA decreassed over thee time of inccubation. Inn polyplexes with
dendritic tetraspermine and PEI (5 kDa), thee release of ssiRNA slighttly increasedd over time aat pH
4.5.
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Chap
pter 3. Na
anoimprin
nting of top
pographiccal and 3D
D cell cultu
ure scaffolds
3.1.

Abstract
A
Thee extracellu
ular matrix exhibits several
s
nanoostructures such as ffibres, filam
ments,

nanoporees, and ridgees which can
n be mimickeed by topogrraphical andd three dimennsional substtrates
for cell and tissue culture forr an environment clos er to in viivo conditioons. This reeview
summarises and discusses a grrowing num
mber of repoorts employiing nanoimpprint lithogrraphy
(NIL) to
o obtain succh scaffolds.. The differrent NIL meethods as w
well as theirr advantagess and
disadvan
ntages are deescribed and special atten
ntion is paidd to cell cultture applicattions. We diiscuss
the impaact of materiials, nanotop
pography, siize, geometrry, fabricatioon method, and cell typpe on
growth guidance
g
and
d differentiaation. We prresent exam
mples of celll guidance, iinhibition of cell
growth, cell
c pinning, and engineeering of 3D
D cell sheetss or spheroidds. As curreently applicaations
are limited and not systematically compareed for variouus cell typees, this revieew only sugggests
ng substratess for particu
ular applicattions. The ooutlook proposes possible directions in
promisin
which thiis field may proceed from
m here.
Keyword
ds: Nanoimp
print lithograaphy, scaffold, substratee, cell culturee, cell guidannce
•

Thiis article rev
views different techniquees of Nanoim
mprint lithoggraphy (NIL)) and their
app
plications as cell substrattes and sugg
gests promisiing applicatiions.
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3.2.

In
ntroduction
n
Bio
o-mimicking
g the naturaal environm
ment of the cell has aattracted greeat interest. The

extracellu
ular matrix (ECM) of th
he cell exhib
bits several nanostructurres such as fibres, filam
ments,
nanoporees and ridgees [1-5]. The cell interaacts chemicaally and toppographicallyy with the ECM
componeents, thus reegulates celll responses like motility
ty, differentiiation and pproliferation, and
many mo
ore. [6-10]. Understand
ding the morrphology annd topographhy of the ceells is cruciaal for
biologicaal, medical and bioeng
gineering reesearch app lications. M
Many techniiques have been
presented
d in the literature, wh
hich aim to
o mimic thhe ECM byy developinng topograpphical
nanostrucctured scaff
ffolds, in co
ontrast to petri
p
dishess. Among the preparaation techniiques,
nanoimprrinting litho
ography is a rather neew one whhich attracteed much atttention receently.
Nanoimp
printing tech
hnology has many prom
mising appliccations in thhe areas of bbiosensors, ttissue
engineeriing [11], DNA
D
mappiing as welll as electroonics. Nanooimprinting techniques have
advanced
d to build to
opographicall and even three
t
dimenssional 3D suubstrates whhich are a crritical
for ex-viv
vo cell and tissue
t
culturiing.
Thee convention
nal in vitro 2D cell cultture does noot mimic thee cell enviroonment in viivo in
terms off the nanosttructure patttern and top
pography ass well as thhe 3D existeence. Nano--sized
substrates can be ob
btained by a variety off conventionnal technoloogies such aas electron bbeam
lithograp
phy [12] or holograpy
h
lith
hography [13]. Non-lithhographic tecchniques that also yield nnanoscale celll culture su
ubstrates aree emulsion freeze-dryinng [14, 15] but are nott discussed here.
Howeverr, the aforem
mentioned teechnologies have some limitations and drawbaacks. As earrly as
1911, Haarrison show
wed that topo
ography play
ys an importaant role in thhe cell behavviour on fibrres of
a spider’s web [16]. Many reseaarch groups used
u
nanoim
mpriting techhniques to sttudy such efffects.
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Extensive reviews discussed the effects of surface nanotopography and bio-interfacial
interaction, which is the interface between the cell and other fabricated material, on cell behavior
in terms of motility [17], alignment [18], adhesion [19, 20], migration [21], differentiation [22],
proliferation [23], nerve regeneration [24] and others [25-29]. Much distinctive behaviour was
observed for cells cultured on nanopatterns versus micro patterns, especially in anchoragedependant cells like neural cells including the dynamics of its membrane, elongation of axonal
fibers to reach its specific targets, the growth pathway, and the cytoskeletal rearrangement that
regulates the directional cell motility. Results vary according to the cell type, topography
nanostructuctures and culture conditions [30]. The methodology applied for scaffold alignment
also affects the alignment of cells with the nanotopography. Chaurey et al. described that
fibroblasts oriented similarly on electrospun vs. nanoimprinted scaffolds for fiber larger than 100
nm. However, cell alignment was more efficient on sub-100 nm nanoimprinted fibers [31]. The
reason for these differences in cell behaviour is that many peptides which are ECM components
(such as laminin [32] and fibronectin) exist in nanoscale. Generally, nanopatterned structures on
substrate surface were shown to induce cells to change morphology, alignment and adhesion
compared to flat surfaces [33]. Dalby and coworkers cultured fibroblasts on 13 nm islands.
Fibroblasts were found to have an increased cell attachment and spreading compared to a planar
surface which were reflected by up-regulation of specific proliferative genes [33]. Later on, the
same group used nanotopograhy as a non-invasive tool to understand the mechanism the
mechano-transduction cascade of gene expression in fibroblasts [34].
Wieringa et al. studied the effect of nanotopography effect on F11 a root-ganglion derived
cell line in terms of cell contact guidance. Contact guidance is the induced effect of the
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anisotropic topographic structures on the cell regarding the alignment and migration in the
direction of the topographies [35]. F11 is an established model for studying cytoskeletal
rearrangement, plasticity [36] and differentiation [37]. Wieringa et al. presented the F1 cell line
as a potential peripheral sensory neuron model for nanotopographical guidance [38]. Substrates
with two different ridge dimensions of 500 nm and 2000 nm and a constant groove width of 500
nm were used to culture the cells. Another factor, the percentage of fetal bovine serum (FBS) in
culture media was considered. In regards to the neurite guidance, no difference was shown
between patterned and flat surface when cultured with 1% FBS. In contrast, when cells were
cultured with 10% FBS, it was shown that the patterned surfaces induced the cell alignment with
a trend of decreasing neurite alignment with increasing ridge width.

This supports the

hypothesis that the cell alignment on nano-patterns occurs differently than on flat unpatterened
surfaces and thus might influence the reliability of other aspects such as nerve regeneration. It
also suggests that sometimes, a set of culture conditions can control the cell response rather than
only one condition. A different report by Lee et al. describes osteoblast-like cells cultured on
nano-thin polymer films on which nanopillar features were imprinted with a favourable size of
200 nm. This process changed the contact angle of the thin film and the surface property from
hydrophilic to hydrophobic. When cells were cultured on hydrophobic nanopillar surface, they
showed poor spreading and adhesion, which might be due to the deprived adhesion on top of the
nanopillars. This represents therefore a cell substrate model that resists the cell adhesion and
spreading. Additionally, it was found that the most important factor in terms of the contact angle
of the nanopillar with the plastic thin film is the temperature of imprinting and de-molding of the
nanostructures and not the imprinting time [39].
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Ho
owever, the mechanism
m
of
o cell respo
onse correspoonding to diifferent nanoopatterns rem
mains
unclear [40,
[
41]. Ty
ypically, it is a trial and
d error approoach to exam
mine the ressponse of thee cell
towards a substrate nanopattern. So far, thee literature pprovides refference to suuch patterns with
specific cell lines. Over
O
the lastt decades, many
m
fabricaation methodds, inspired by the natuure of
ECM haave been in
nvestigated. Some of th
hem are noovel techniqques. Otherss are establlished
fabricatio
on methods that are mo
odified to overcome
o
onne or more drawback oof an establlished
method. In this review, we descrribe basic nan
noimprint litthography teechniques thhat can be appplied
ographical and
a three dim
mensional sccaffolds for ccell and tissuue culture annd we
for patterrning of topo
discuss th
he applicatio
ons and posssible future development
d
ts.
•

Nanotopography significantly
y affects celll behaviour. In order to m
mimic the inn vivo condittions
of thee cell growth
h, it is necesssary to consiider the patteerns and topography of tthe extracellular
matrix
x (ECM) nan
nostructuress and to incorporate them
m in the propposed cell suubstrate.

3.3.

Nanoimprint
N
t lithograph
hy (NIL)
Nanoimprint liithography [42] is a top
p-down nanoo-patterningg technique w
with sub-100 nm

high reso
olution and high
h
through
hput at low cost.
c
NIL meethods are cllassified as tthermoplastiic (TNIL) an
nd ultra-viollet nanoimp
print lithogrraphy (UV--NIL) methoods [43, 444]. Additionnally,
variants to
t those two
o techniques exist. Nano
o-patterns caan be formedd on differennt substrates such
as glass plates, siliccon wafers, flexible po
olymer resis ts and non--planar subsstrates [45]. NIL
m
advan
ntages over other
o
conven
ntional opticaal lithographhic techniquees that depennd on
exhibits many
electron beam scatteering or lig
ght diffractio
on since NIIL adapts a different cconcept whiich is
causing a uniform mechanicall deformatio
on onto thee substrates [42]. In N
NIL, mechaanical
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embossin
ng is applied
d on the resissts that later serves as a replica of thhe original pattern. Usingg this
techniquee allows forr avoiding th
he limitation
ns associateed by electroon beam scaattering and light
diffractio
on such as the lower resolution [46, 47]. M
Moreover, N
NIL demonnstrated ultraahigh
resolution
n shortly affter its introd
duction [48]]. However, NIL is assoociated withh various etcching
and depo
osition proceesses [49], which
w
increaase the timee and the coost of the prrocess. Therrefore
NIL is not
n suitable for commerrcial large- scale produuction, howeever, on the lab-scale, iit has
many adv
vantages and
d application
ns [50].
•

Nanoimprint litho
ography (NIL
L) presents many
m
advanttages over oother conventional
niques. NIL methods
m
can
n be subdivid
ded into therm
mal, ultravioolet and variiant NIL
techn
techn
niques.

3.4.

Thermoplast
T
tic NIL (T-N
NIL)
NIL
L, first intro
oduced by Chou
C
et al in
i 1995 [42]] was calledd “hot emboossing”, andd then

developeed to what we
w now undeerstand as NIL.
N
In the tthermoplastiic NIL (T-N
NIL), as show
wn in
Figure 3..1, a fine lay
yer of a therm
moplastic po
olymer is deeposited on a substrate w
which is a siilicon
wafer and is spin coaated to form the surface of the impriint resist. A hard mould,, usually maade of
w
pre-paatterned nan
nostructures is embosseed in the rresist surfacce by a theermosilicon, with
mechaniccal single steep under preessure to staamp the desiired nanostruuctures of thhe mould intto the
polymer resist. The thermoplastic polymerr temperaturre is elevateed above itss glass transsition
ure (Tg) to facilitate
f
the flow of the polymer
p
intoo the nanocaavities of thee hard mouldd [51temperatu
54]. Consequently, th
he temperatu
ure of the po
olymer is low
wered below
w Tg to freezee and solidiffy the
replicated
d patterns an
nd to detach
h the mould, thus leavinng the patternn on the subbstrate [52]. Only
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two yearrs after this initial
i
reportt, sub-10 nm
m structures as small as 6 nm were constructed [48].
The high
h imprinting temperaturee well above Tg and the hhigh pressurre (50-100 bbar) represennt the
main lim
mitations of the
t T-NIL teechnique [55
5], in additioon to the meechanical strrain involveed. At
this high
h temperature, the polym
mer exists in
n a viscous liquid form under presssure, and theereby
can occu
upy the cavitties of the mould.
m
The main
m
principple of NIL iss based on ssqueeze flow
w of a
sandwich
hed viscoelaastic materiall between a substrate annd a mould. Many attem
mpts to overcome
these lim
mitations weere reported
d, such as room
r
tempeerature NIL

[56-58] aand low preessure

nanoimprrint lithograp
phy [59].

Figure 3..1: Schematiic illustration
n of thermall NIL. (a) A fine layer of a thermo-pplastic polym
mer is
deposited
d and spin-ccoated on thee substrate, a silicon waafer. (b) A hhard mould, usually maade of
silicon, contains pree-patterned nanostructu
ures and is mechanicallly embosseed into the thin
polymer film at high
h pressure (5
50-100 bar). The temperrature of thee polymer iss raised abovve Tg
for a few
w minutes to
o allow the flow of thee polymer rresist into thhe mould caavities. Then the
temperatu
ure is lowered to solidiffy the pattern
ns. The mouuld is detacheed to leave tthe pattern oon the

83
substrate. A thin ressidual layer that is orig
ginally left on purpose to avoid thhe direct coontact
between the substraate and the hard mould
d is then reemoved by reactive ionn etching (R
RIE).
Adapted from [11]

Figure 3..2: Schematiic illustration
n of UV NIL
L. (a) The suubstrate is cooated by a U
UV-curable lliquid
polymer resist. (b) A transparent mould (quaartz glass) is pressed intoo the substratte. The imprrinted
ured by UV-radiation app
plied to crosss-link the poolymer resisst and to faciilitate
nanostrucctures are cu
pattern formation
f
on
n the substraate at room temperaturee and underr reduced prressure (0-5 bar).
Subsequeently, the mould
m
is releaased leaving
g the imprinnted structurres on the suubstrate. Adapted
from [11]
Thee resist used is a key in the proccess; usuallyy a polymerr curable uppon heat or UVexposuree is used. Th
he material of the resistt can be choosen dependding on the adhesion deesired
between the resist an
nd the templaate [60]. Varriable materiials can be uused with diffferent propeerties.
Regardin
ng the moulld manufactture, a hard
d mould is typically ffabricated byy electron bbeam
lithograp
phy, focused
d ion-beam etching
e
and dry etchingg techniquess [61], or a variety of other
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innovativ
ve techniquees to yield a high nano
o-sized resoolution [62]. Many reviiews on typpes of
moulds, resists and conditions of the NIL
L process [447, 63-65] and commeercially avaiilable
m
[66] have been published. Geenerally, thee considerations for the m
mould fabriccation
imprint moulds
include th
he hardness,, thermal exp
pansion coeffficient and compatibilitty. Variablee parameterss such
as the ch
hemical, phy
ysical pattern
ning and meechanical asppects as welll as the inteerface interaaction
and its effect
e
on mo
ould filling and
a the de-m
moulding prrocess [67-669] play an iimportant roole in
NIL.
•

Therm
mal nanoimp
print lithograaphy (T-NIL
L) relies on thhe mechaniccal embossinng of a mould
into a thermoplastic resist. Main limitatio
ons are the hiigh temperatture and presssure appliedd.

3.5.

Ultra-violet
U
NIL
N
Ulttra-violet naanoimprint lithography (Figure 3.2)) is perform
med by coating the substrate

surface with
w a UV-cu
urable liquid
d resist. An optically-traansparent moould is usedd to press intto the
substrate, and then UV
U radiation
n is applied to
t solidify thhe resist. It provides sevveral advanttages,
such as reduced
r
cyclle time, loweer cost, as well
w as polym
merisation aat room tempperature [44]. All
these facctors yield to
o the successs of UV-NIL. Howeverr, it is difficcult to repliccate patterns with
high aspeect ratio and
d high densitty with UV-N
NIL. This iss due to the high force nneeded to rem
move
the patterrn formed frrom the mou
uld. In an atttempt to ovvercome thiss challenge, an anti-refleective
glassy caarbon mould was used to
o aid in the reelease of thee pattern from
m the mouldd. Results showed
that the force
f
of releaase is depend
dent on the surface
s
area of the mouldd [70].
Strrong and sign
nificant advaances have improved
i
thhe nanoimpriinting processs throughouut the
years. Steep–and-flash
h imprint lith
hography (SFIL) is one oof them. In tthis techniquue, a monom
mer of
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low viscosity is deposited as drops by ink jet printing without spin coating. The template is then
lowered to a contact point with the resist. The resist flows to fill in the gaps between the
substrate and the template topographies by the capillarity effect. Subsequently, UV irradiation is
applied to cause polymerisation. The lowest possible pressure (<0.02 atm) among all other
techniques is used in SFIL. The drop injection renders SFIL useful for patterning on non-planar
surfaces [71]. Step and flash imprint lithography (SFIL) is a good example for an optimised
automated operation with reduced defects and contamination [72]. The alignment accuracy is
about 10 nm [73]. Glangchai et al. used SFIL to form nanoparticles with uniform 50 nm size and
shape using macromers. These nanoparticles are enzymatically-triggered to release an
encapsulated drug. This novel incorporation of nanoimprinting represents a high-throughput
technique with a precise control of the nanoparticles size. SFIL requires neither high temperature
nor exposure of UV radiation for a long time. SFIL showed many advantages such as the high
accuracy of alignment and uniformity. Besides, it can be used to imprint over a pre-patterned
resist. This property suggests that SFIL can perform multi-layering of resists and form 3D
scaffolds [74].
Other developments have been studied to improve the conditions of NIL. The air cushion
technique used to enhance the uniformity of the applied force was shown to increase the yield as
well [75]. Other developments were the incorporation of a biological sample as a template in the
process [76], reduction of temperature and pressure applied [77], polymerisation at room
temperature [57], and others [78-83].
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•

In ultraviolet
u
NIL,
N a transpaarent mould is pressed innto a photorresist, and thhen UV radiaation
is applied
a
to haarden the resiist at room temperature. Limitationss are the diffficulty to obttain
pattterns with hiigh density and
a high asp
pect ratio.

3.6.

NIL
N variantss
Oth
her variants of NIL emerged, such as
a step and sstamp nanoim
mprint lithoggraphy SSIL
L [84-

87], NIL
L using waafer stampss [88-90], electro-chem
e
mical nanoim
mprint lithoography, reeverse
nanoimprrint lithograaphy [55], su
ubstrate con
nformal imprrint lithograaphy, ultrasoonic NIL, rooll-toroll NIL, and laser asssisted directt imprint rev
verse imprintt lithographyy [63, 64].
Eleectrochemicaal nanoimpriinting involv
ves using a m
mould fabriccated from a solid electrrolyte
or superiionic conducctor. When the
t mould contacts
c
the substrate, a voltage is aapplied to innitiate
electroch
hemical etch
hing that dissolves
d
th
he metals inn the mouuld. Metal ions formed by
electroch
hemical etch
hing are theen transferreed from thee film to the mould. A complemeentary
pattern to
o the mould
d with sizess of 50 to 500 nm on m
metal silver surface aree formed [91]. A
continuou
us roll-to-roll NIL (R
R2RNIL) teechnique caan imprint nanostructuures with highthroughp
put and speeed. Ahn et al.
a demonstrated a roll--to-plate im
mprinting (R22PIL) on a rigid
substrate as well as R2RNIL
R
on a flexible web
w to transfe
fer nano-grattings in a larrge area of 4 inch
wide with high-throu
ughput. The continuity of
o the techniique providees a uniform
m applied preessure
on the resists [92]. Continuous UV
U roll NIL technology
t
w
was also desscribed [93].
M
Mo
olecular imprints Inc. inttroduced thee jet and flassh imprint litthographyTM
(J-FILTM, 22009)

which is used to dessign a nanop
pattern layer-to-layer allignment in semiconducctor and meemory
devices with
w high resolution, extendible to sub-10
s
nm rresolution annd low cost production. Low
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viscosity
y imprint fluiids are used, of which a drop is dispeensed in a coontrolled-onn-demand-maanner
dependin
ng on the template paattern desired. These two properrties, the aadaptive maaterial
dispensin
ng and the lo
ow viscosity
y nanoimprin
nt fluids ressults in contrrol of the reesidual layerr with
dimensio
on uniformitty. This tecchnique is performed
p
aat room tem
mperature aand uniform
m low
pressure,, which is ad
dvantageous. Furthermorre, the transpparent tempplate used in J-FILTM is a key
to yield a high resolu
ution layer-to
o-layer align
nment.
•

Maany variants of NIL havee developed to
t either proovide differennt parameterrs and
adv
vantages or to
t avoid speccific limitations of establlished technniques.

3.7.

Reverse
R
nano
oimprint litthography
Rev
verse nanoimprint litho
ography (RN
NIL) [55, 944] is a relaatively recennt techniquee that

inherits the
t concept of
o conventio
onal NIL and
d adapts advvantages over it. In conventional NIL
L, the
substrate is spin-coatted by a poly
ymer layer before
b
beingg stamped byy a hard mouuld to deform
m the
polymer film and to create thick
kness contrasst. Hence, hiigh temperatture and pressure are needed,
MPa [95-97]]. Noticeablly, in the reeverse
typically at least 70°C above Tg and presssure of 10 M
nanoimprrinting techn
nique (RNIL
L), the liquiid polymer rresist is pouured into thee mould witth no
pressure applied, spiin-coated an
nd cured by thermal appplication. Heence, a replica of the m
mould
pattern is formed in
n the polym
mer resist, th
hen peeled off and traansmitted to the substraate at
appropriaate pressure and temperrature as sho
own in Figurre 3 [11]. T
This advantagge allows foor the
usage off substrates which are hard to be spin-coatedd with a poolymer, for example fleexible
polymer substrates [55].
[
Also the
t reduction
n of temperrature and ppressure com
mpared to T
T-NIL
shortens the time of the imprinting and easees the changge of the paattern upon ccooling [98]. The
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consequeentially transsffered patteern is used as
a a substratee for cell cuulture or as a negative m
mould
for a new
w nano-imprinting proccess which allows
a
for enhancing tthe durabilitty of the oriiginal
mould.

Figure 3..3: Schematiic illustration of reversee nanoimprinnt lithographhy (RNIL) ((a) A mouldd with
desired nano-feature
n
s is used. (b) The liquiid resist is ppoured into tthe mould structures wiithout
pressure. The resist is spin-coated and cured by thermal or UV crosss-linking. (c)) The cured resist
d off and tran
nsferred to either a substtrate or to prre-patterned resists to form topograpphical
is peeled
substrates for cell cu
ultures. The resulting su
ubstrate can be directly used as a ceell substratee or it
can be used
u
as a neegative mou
uld for anoth
her imprintiing process and can heence increasse the
durability
y of the master mould. Adapted
A
from
m [11]
Hu
uang et al. su
uccessfully transferred
t
th
he patterns ffrom the moould to the ssubstrate by three
different modes i.e. inking, emb
bossing, and whole-layerr transfer. T
This was donne by controolling
both thee temperatu
ure and thee surface planarisation
p
n of the poolymer resiist. The suurface
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planarisation is characterised by the average peak-to-valley height of the coated resist. The
solution used for spin-coating is the parameter that most strongly controls the thickness of the
layer. By adjusting the degree of surface planarisation after spin-coating, pattern transfer can be
accomplished in the inking and whole-layer transfer modes at temperatures and pressures as low
as 30 °C below Tg and 1 MPa, respectively, which is significantly beneficial. At this lower
temperature, the pattern transfer was found to be strongly dependant on the planarisation degree.
If the polymer coating is non-planarised on the mould, the protruded areas only will be
transferred to the substrate, resulting in so called inking pattern transfer. But if the polymer is
planarised, then the entire polymer coat is transferred to the substrate which is called whole-layer
transfer. The nature of these two modes only requires minimal dislocation of the polymer film
which renders RNIL less prone to polymer flow problems [55].
To reduce the high temperature and pressure requirements, Borzenko et al. modified the
conventional NIL by applying the polymer bonding method. In this method, the polymer is
applied on both the mould and the substrate to facilitate their bonding at reduced temperature and
pressure. A specific treatment is used to leave the polymer on the substrate only after cooling.
However, this method leaves a thick residue layer after the imprinting which complicates the
subsequent transfer steps [99, 100].
•

Reverse nanoimprint lithography (RNIL) is similar to T-NIL; however the thermoplastic
resist is applied on the mould rather than the substrate. RNIL provides opportunities to use
a variety of flexible polymer substrates which are difficult to be covered with a polymer.
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3.8.

Reverse
R
UV--NIL
In this
t method,, a liquid UV
V- curable polymer
p
resisst is dispenssed in a mouuld which is spin-

coated, and
a then cured by UV- cross-linking
c
g to form thhe desired naano-patterneed structures. The
patterned
d resist can either
e
be tran
nsferred to a substrate too act as a funnctional celll culture substrate
or can bee transferred
d to a pre-pattterned resisst to build upp a three-dim
mensional (33D) scaffold [11].
Combinin
ng RNIL wiith UV-NIL enables 3D structuring aat reduced teemperature aand pressuree. Hu
et al. fab
bricated micrro and nanosstructures off an adhesiv e material, S
SU-8, at 50 °C, 1MPa annd 1s
of UV exposure.
e
SU
U-8 is a co
ommonly ussed epoxy-bbased negatiive photoresist. It is hhighly
transpareent in the UV
V-range whicch renders itt ideal for im
maging. Grattings of sizes from 100 nnm to
1 μm were formed. This
T processs was repeatted to yield cavities andd channels w
with sizes rannging
from 400
0 nm to 10 μm
μ [98]. Thee 3D patterniing of nanoim
mprinted subbstrates is thhe first step iin the
developm
ment of nano
oimprinted ceell culture sccaffolds.
•

3.9.

Rev
verse ultra violet
v
NIL is related to UV-NIL;
U
how
wever the photoresist is aapplied on thhe
mould rather th
han the substtrate.
Combination
C
n of NIL witth other techniques forr cell culturee applicatioons
Many research
h groups com
mbined both
h types of NIIL with otheer methodoloogies to optimise

he alternativee competitiv
ve methods i s microcontaact printing (µCP) which is a
the resultts. One of th
lithograp
phic method.. It is an ink
king approacch in which an elastomeeric stamp iis used withh selfassembleed monolayeers (SAMS) which acts as
a the ink. C
Consequentlyy, The SAM
MS are transfferred
to the sub
bstrate for further
fu
charaacterisation and
a processiing of the chhemical surfface [101]. H
Hu et
al. reporrted the fabriication of a hybrid
h
envirronment of nnano and micro structurees using softt UVNIL, pho
otolithograph
hy, reactivee ion etch (RIE) techniiques as weell as microo-contact priinting
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(µCP) [102]. The formed nanopatterns were used to grow Hela cells. Results showed alignment,
elongation as well as preferential localisation of cells at the nanolines formed. Another example
for the combination of techniques is that of laser interference lithography (LIL) and UV-NIL.
Although LIL is a simple, quick and easy method to fabricate nanopatterns, it has some
limitations, namely the non-selectivity of produced patterns and difficulty of size restriction of
maximum and minimum structures. On the other hand, fabricating master stamps by NIL is
costly. In order to reduce the costs, LILL is used to fabricate the master stamp, subsequently,
NIL is performed to form replicas used as cell substrates. Combining both techniques is
advantageous to limit the non-selectivity of LIL as well [103]. Therefore, Lee et al. used LIL to
fabricate a master stamp where a quartz wafer was coated with a photoresist of 1 μm thickness.
Two series of laser exposures were performed at the interference state. The sample was rotated
by 90 degrees before the second exposure. The photoresist was hard-baked to develop the
patterns. These nano-patterns were then transferred by a reactive ion etching (RIE) process onto
a quartz wafer coated with a Cr layer. At this point, a negative replica is produced. A further
RIE process was performed onto a quartz substrate to obtain a positive replica. The produced
replicas are used as substrates for cell culture. Two patterns were obtained, i.e. a dense pattern
and a scarce pattern. Patterns 1 and 2 are nanopillars round in shape, 123.3 and 130.1 nm in
diameter, 200 and 500 nm in height, with an interval of 163.6 and 438.7 nm, respectively. The
ratio percentage between pattern area and unit surface area of original flat surface was ~14.5 for
pattern 1 and ~4.1 for pattern 2. Human osteoblasts (hFOB1.19) were cultured on the two
patterns as well as on a flat control surface. Cells on scarce patterns showed good adaptation to
the pattern and filopodial extension with high directionality. Cells on dense patterns showed
filopodia with different turning points that indicated difficulty in finding the pathway of
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migration. The authors concluded that the contact guidance is dependent on the ratio of the
pattern surface area to the pattern interval [104]. Rajput et al. recently used nanoholes with a
gradient array of relative spacing ratios on a fused silica layer to form nanoneedles structures.
Using nanoimprinting, the negative replica of the nanoholes was extracted by a polymer layer, on
which silica was placed to form nano-needles. The pattern varied from 10 μm to 50 μm in one
micron increments in both orthogonal directions in a spatial 2D gradient array. When fibroblasts
were cultured on nanoneedles, an enhancement in cell adhesion was observed compared to flat
silica surface which is due to the interaction between ECM components and nanoneedles, and
prevention of cell aggregate formation [105].
As described in the introduction, the mechanism of cell response to different nanopatterns had
been poorly understood before the emerging of NIL. Cells cultured on hydrophobic nanopillar
surfaces had shown poor spreading and adhesion [39]. Later, the role of the type of
nanotopography in guidance and cell spreading was investigated in 2010 by Hu et al. The
authors used nanoimprinting followed by demould-induced feature elongation to obtain
nanopillar topographies with pillars larger than the mold depth. After seeding human foreskin
fibroblasts on nanopillar topographies with 150 nm, ∼700 nm, or 1 μm in height, these cells also
spread poorly on both the hydrophobic and hydrophilic nanopillar surfaces due to the restricted
area at the tops of the pillars which did not suffice for the formation of micron-scale focal
adhesions between the cells and the surfaces. The authors therefore suggested nanopillar
topographies for surfaces on which cell spreading needs to be avoided [106].
In a study by Xie at al., on the contrary, nanopillar arrays were used to pin the position of
neurons and to serve for better cell attachment. Similary, as in the report described above, the
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nanopillar dimensions were 150 nm in diameter, and 1 μm in height. However, Si and SiO2
nanopillar substrates on platinum and quartz material were chosen for biocompatibility. After
pinning the neurons to the nanopillars, the authors observed inhibited migration of the cell body.
However, axons and dendrites were observed to freely grow and elongate into the surrounding
area [107]. It becomes clear that on a similar nanotopography, different cell types can behave
very differently, and that the substrate material plays an important role also.
Another example for the fact that the combination of two parameters, rather than one [38],
namely topography and culturing time, can significantly change the cellular alignment fibroblasts
was reported by Loesberg et al. The authors determined the orientation angle of cells by
measuring the angle between the direction of the grooves and the direction of cell growth which
was determined by the maximum cell diameter to determine cell orientation. Loesberg et al.
found that fibroblasts seeded on nanogrooved polystyrene (PS) substrates had aligned with the
nanotopography of the substrates after only 4 h if the grooves were at least 100 nm wide and 75
nm deep. Contact guidance reflected in fibroblasts orientation according to the grooves was even
observed in only 35 nm deep grooves 24 h after cell seeding. The authors therefore concluded
that the grove depth is the most determining parameter, although interdependence with culture
time becomes obvious [108]. This is in contrast with a value reported by Dalby et al., who
showed that lamellapodia and filopodia still show interaction with random nano islands as
shallow as 10 nm [33].
Nanotopographical substrates were also used to investigate nuclear deformation in human
mesenchymal stem cells as it is known that nanoscale features can initiate cell-matrix adhesion
signals that, mediated by the cytoskeletal network, are transduced to the nucleus. Chalut et al.
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therefore used a combination of soft lithography and T-NIL to obtain nanograted
poly(dimethylsiloxan) (PDMS) and PS substrates which were coated with collagen for cell
culture purposes. The authors were able to show by fluorescence microscopy and live cell
imaging that nuclei of stem cells oriented and extended along the axis of the grating if grown for
48 h on nanograted the PDMS or PS substrates. They also found that the mechanical properties
of the substrate were an important parameter as shown by more rapid nuclei elongation on the
stiffer PS substrates [109].
Johansson et al. also found that sympathetic and sensory ganglia cultured close to nanoprinted patterns in polymethylmethacrylate (PMMA)-covered silicon chips showed axonal
outgrowth on ridge edges and elevations only tone week. The authors used electron beam
lithography (EBL) and T-NIL to fabricate PMMA-covered silicon wafers and fast Fourier
transform (FFT) analysis in order to quantify the alignment of the axonal outgrowth of ganglia.
They described that axons were guided by nanoimprinted polymer patterns of at least 100 nm
and concluded that the ratio of axon diameter and groove width was the major determinant
affecting axonal guidance [110].
Crouch et al. directly imprinted tissue culture polystyrene (TCPS) with gratings of various
pitches and depths using T-NIL after preparing their molds by UV contact photolithography and
inductively coupled plasma (ICP) etching. To obtain 3D collagen-like structures with nano- and
microstructures, they used double-imprinting. Human foreskin fibroblasts were seeded on the
substrates and fixed 24 h later and found to align and elongate efficiently at increased aspect
ratios of the nonpattern width and depth. Although they found that the aspect ratio can describe
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the cell behaviour, they also acknowledged that differences in cell types, culture conditions, and
structure variation makes predictions difficult [111].
Although by far the most studies investigating cell guidance on nanotopographies have
employed fibroblasts, other reports describe the growth of cells such as mesenchymal stem cells
[109], neurons [107, 110, 112], astrocytes [113] or cardiac aorta endothelial cells [114] on
nanoimprinted substrates. In a study investigating astrocyte reactivity, Ereifej et al. used UVNIL and pre-made reflective holographic-grated molds to obtain poly(methyl methacrylate)
(PMMA) patterned substrates with either a period of 3600 grooves/mm or 1800 grooves/mm.
The authors found that C6 rat astrocytoma cells seeded on the differently nanopatterened and
non-patterened substrates showed less protein adsorption, less cell adhesion, proliferation, and
viability if seeded on the 3600 nanopattern surface. They concluded that this particular
nanopattern could be beneficial for the fabrication of neural electrodes to avoid glial scarring and
astrogliosis after microelectrode implanation [113].
Similarly, Baranes et al. demonstrated that leech neurons growing on nano-scale linepattern ridges develop more simplified neuronal branching tree [112]. Their observations that
small filopodia attach to the nano-ridges which guides the neuronal growth direction is in line
with findings by Johansson et al. described above [110].
In another example of neuronal cell culturing on nanoimprinted substrates, the impact of
topographical noise, such as protein aggregates [115], and cellular debris [116], on the guided
growth of neuritis was investigated. Tonazzini et al. used T-NIL to produce noisy nanogratings
of 500 nm ridge and 500 nm grooves. Different substrates with variable percentage of noise and
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cell-dependant directionality were fabricated. Differentiating neuronal PC12 cells were cultured
on the patterned substrates, and observed for alignment and guidance. Results showed that the
loss of neurite guidance is not linear to increasing the topographical noise. It is rather a threshold
effect that is associated with the spatial arrangement and the focal adhesion (FA) maturation.
Lastly, an antineoplastic drug, that promotes cell contractility, nocodazole, stimulated aligned
FA maturation when incorporated in the scaffold and hence boosted the alignment. This suggests
that using specific drugs can modulate the cell culture conditions and cellular growth on cell
substrates [117].
In 2009, Idota et al. used graft-polymerisation with an electron beam (EB) lithography
system to fabricate temperature-responsive micrometer and nanometer-patterned poly(Nisopropylacrylamide) (PIPAAm) layers with a 200 nm line-width. The authors found that
fibroblasts and cardiac aorta endothelial cells growth was guided by the pattern orientation at
temperatures above the lower critical solution temperature (LCST) but detached, shrunk and
folded along the pattern below the LCST. It was concluded that this nano-scale system may
allow engineering of functional 3D cell sheets or spheroids [114].
Table 3.1: Classification of nanoabrication methods in terms of type of energy sources. For each
method, important characteristics, polymer used, advantages and disadvanatages are
summerised.
Source of Technique

Important

Energy

Characteristics

Thermal

Advantages

Disadvantages

Referenc
es

Thermal NIL

Physical deformation High resolution.

High temperature

[42] [48]

(T-NIL)

of

High pressure (50-

[118]

thermoplastic High throughput.

polymer above Tg

Low cost.

100 bar)
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Simple set-up.

Mechanical tension

Short procedure.

Reverse

NIL Thermal

cure

applied

(RNIL)

resist.

to

is Possible

for Pattern transfer can [47, 51]

liquid substrates that are not be challenging

Pattern

is suitable

for

spin-

formed on mould then coating

and

those

transferred

to with

substrate.

surface

topographies.
Short process.
No external pressure.

Optical

Ultraviolet

UV curable polymer Room temperature.

NIL (UV NIL)

resist dispensed and Low
spin-coated

pressure

(0-5 patterns with high [118]

on bar).

substrate.

Hard to replicate [44]

density

and

high

Short process.

aspect ratio.

Low cost.

Difficult to release
pattern from mould.

Reverse

UV UV

NIL

curable

resist.

liquid Enables 3D

Pattern

is patterning by

Pattern transfer can [98]
be challenging.

formed on mould then repeating the process.

Chemical

transferred

to Reduced temperature.

substrate.

Reduced pressure.

Microcontact

Pattern transfer to a Simple.

Stamp deformation [101,

printing (µCP)

substrate

during

relative

through Low cost.
difference Versatile.

removal 119-121]

from template.
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betweeen

surfaace Elastomerric

energ
gies.

afford
mechaniccal
to

printt

stamps Lower resoluttion of
sufficient patterning

and

strength decreased
500

nm reproducibilityy.

structuress.

Contaminationn with
uncured fragm
ments.
Swelling of sstamps
by organic sollvents.

Electrica
al

Electro-

Electrrochemical

Yields

chemical

oxidaation/reduction

accurate sstructures.

deposition
n

betweeen

conductiive

highly Only applicabble to [91] [122,
conductive orr ionic 123]
materials.

and io
onic interfaces..

•

Com
mbining more than one nanoimprint
n
t technique aas well as othher distinct m
methods cann
acccount for opttimising the resultant
r
pattterns and el iminate unddesired fabriccation steps.
Mo
ost cell culture substratess were fabriccated throughh a combinaation of methhods, and
sub
bstrates that promote
p
celll guidance, that
t pin cellss to a certainn area, that innhibit cell
adh
hesion, or thaat allow for the growth of
o spheroids are discusseed.

3.10.

3D
D patternin
ng
In reality,
r
the fabrication
f
process
p
of a 3D environm
ment can bee expensive and compliccated.

Several conventionaal techniques can con
nstruct com
mplex 3D nnanoscaffoldds, classifieed as
lithograp
phic and non
n-lithograph
hic techniquees. Lithograaphic techniiques includde electron bbeam
lithograp
phy [124] an
nd soft litho
ography [125
5], capillaryy force lithoography [1266, 127], pollymer
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transfer printing,
p
deccal-transfer lithography [128], and ion projecttion lithograaphy as reviiewed
[129, 130
0]. NIL can
n be used to build 3D su
ubstrates wiith inter-connnected mateerial using ssingle
lithograp
phy by eitheer direct nan
noimprint lithography oover pre-pattterned resissts or by veertical
layer-to-llayer stackin
ng of resists, shown in Fiigure 3.4 [944, 131].

Figure 3.4:
3
3D Pattterning a) Direct nano
oimprint lithhography ovver pre-pattterned resistts. A
polymer resist is disp
pensed in th
he mould to occupy the spaces betw
ween the moould cavities. The
mould is thermally or
o UV cured to fabricate a nanopatteern. This moould contactss a substratee with
pre-patterned nanostrructures to detach
d
and trransfer the seecondary paatterned resisst from the m
mould
to the su
ubstrate. A tw
wo-level patttern is form
med. This proocess is repeeated to form
m the desireed 3D
environm
ment. b) Verrtical layer-tto- layer staacking of ressists. A polyymer resist is dispensedd and
spin-coatted on a substrate. A mo
ould is embo
ossed into thhe resist. Theermal or UV
V cure takes place
to form a nanopattern
n. The moulld is released
d leaving thee pattern on the substratee. This process is
repeated to yield ano
other layer of
o pattern wh
hich is transfferred and sttacked on thhe previous llayer.
This proccess continu
ues with the number of layers
l
essenttial to form a spatial arrrangement foor 3D
growth of
o cells. Adap
pted from [132, 133]

100
In vivo, cells are exposed to physical directional cascade signals due to their existence in a
3D environment with certain topographical noise as discussed above [115, 116]. For example,
cell guidance is also significantly altered if cells are cultured on a 3D scaffold with more than
one type of cells. One example for cross-talk between two different filopodia populations was
reported by Jang et al. The authors provided a 3D model to understand the guidance mechanism
induced by artificial nanotopographies resembling ECM cues in neuronal cells. They used two
different populations of filopodia at the growth cone. UV-NIL was used to fabricate arrays of
parallel ridges (350 nm wide and 350 nm high, separated by grooves of 1, 2, 3, 5 times 350 nm
width increments). Laminin, an ECM protein, was presented on a line nanopattern. The neurite
outgrowth was shown to be oriented along the line pattern and the neurite length increased.
Neurite outgrowth is a conventional behavior of the growth cone involving the two populations
of the filopodia. The authors described the cross-talk between the two filopodia populations
which regulated the sensing mechanism of nanotopographical stimuli. This cross-talk happens by
the integration of the signals originating from the two populations but was not observed on a
non-topographical substrate [134].
Three dimensional moulds can be used in NIL for direct 3D patterning. Li et al. used 3D
moulds in a single-NIL-step. Moulds were fabricated by a single step electron beam lithography
and reactive ion etching (RIE), then imprinted in polymer templates to yield three dimensional
metal T-gates and air–bridge structures of sub 40 nm size [135]. The availability of 3D
patterning stamps can allow for more opportunities and can reduce the cost of the process.
Stamps are fabricated by various techniques, mostly electron beam techniques [136] [137],
focused ion-beam (FIB) milling [138-140], focused ion-beam etching [141, 142] and two photon
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polymerisation [143, 144]. Other advances have developed to overcome the challenges of 3D
mould fabrication [145, 146].
Reverse nanoimprint can be used to construct multi-layer 3D nanostructures as described
before [94]. Tavakkoli et al. used RNIL to fabricate a uniform nanostructured discrete-track
recording media at a 50 nm track pitch in order to increase the current capacity of the magnetic
hard disk recording media [147]. This study revealed even more advantages of RNIL over
conventional NIL, such as the speed of the imprinting process, and a thinner residual layer.
Multi-layered nanostructures can be built by layer-by-layer stacking of nanostructured
layers via reverse nanoimprinting which does not require a planarisation layer and therefore is a
desired technique. Multi-layering has recently been reviewed elsewhere [148, 149]. Multilayering by UV curable resists [150] avoids the formation of unfavourable residual layers and
takes place at relatively low temperature and pressure compared to T-NIL. On the other hand, it
is not easy to detach the cured structures which are used as templates later in the process. In
distinction, thermally curable resists are easily detached, however one limitation to this technique
is the relatively high temperature involved in the pattern transfer step near the glass transition
temperature Tg of the resist which may cause the flowing and deformation of the bottom layer.
To overcome this problem, two moulds with different silane treatment can be used to stack the
two layers [151]. To overcome the high temperature limitation, Bao et al. used reverse thermal
nanoimprinting with reduced Tg to stack three different polymers [94], however this
methodology is limited in the type of polymers that can be used and in number of polymer layers
that can be stacked. Therefore it was necessary to develop a technique to stack multilayers from
one polymer.
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Hu et al. used a simple NIL method to imprint 3D nanostructures on the widely used tissue
culture polystyrene plates (TCPS). The process started by traditional NIL to imprint the first
layer; however the second step was performed at a reduced temperature and pressure to avoid
disturbance of the first layer. The second imprint was repeated for multiple layers to fabricate a
3D scaffold with 350 nm to 10 µm gratings to study the effects of nano versus micro-patterns.
Bovine pulmonary artery smooth cells (SMCs) were cultured on both patterns. Cell alignment
and elongation was significantly higher in cells cultured on nano-patterns [152].
Following a similar strategy, Yoshii et al. developed 3D nano-culture plates (NCPs) by
imprinting into resinous inorganic sheets that were used to culture tumour cells. Tumour cells
grown on NCPs formed cell aggregates and attached to the nano-imprinted scaffold via the
elongated lamellipodia. Consequently, these tumour cells produced multi-cellular spheroids
which resemble in vivo tumour conditions. All these properties were lacking in cells grown on
non-patterned scaffolds. Also it was found that 17 genes were overexpressed in cells grown on
NCPs, including hypoxia-induced factors target genes and genes relevant to intracellular
interaction and multicellular organisation [153].
Yew et al. used a single polymeric material to fabricate double and three-layer residualfree nanostructures using reverse T-NIL [133]. A one dimensional grafting with ridges around
250 nm width and 200 nm depth was transferred from the mould to the substrate in an orthogonal
arrangement. Using a single material ensured avoiding another bonding material and the need for
a planarisation layer. The stacking of the layers occurred at the Tg. On the other hand, some
limitations occurred, such as a 30% compression in the lower layers to guarantee good adhesion
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between them; however, by optimizing the fabrication conditions, such as the pressure, the
compression can be avoided.
Nakajima et al. fabricated multi–layers by applying a differential temperature between the
lower layer (below Tg) and the upper layer (above Tg) [154]. Another recent technique, named
reverse contact UV NIL, was developed by Kehagias et al. in 2007, which is a combination of
nanoimprint lithography and contact printing lithography. The main purpose of combining these
two techniques is to obtain 3D wood-pile like nanostructures and to transfer this pattern with no
residual layers. This technique avoided the undesired etching processes that are typically
necessary to remove the residual layer [155]. In 2013, Han et al. used RNIL to fabricate 3D
nanostructures with a UV curable resin and a resin of dispersed zinc oxide (ZnO) nanoparticles
[131]. The UV-curable resin was transferred from a silicon stamp to a substrate as a 2D dualsided pattern layer. In this transfer step, a diluted UV-glue was used to increase the adhesion
force between the pattern layer and the substrate without generating a thick residual layer. A
ZnO dual side patterned layer was also fabricated. ZnO nanoparticles of 40 nm in size were used
as a higher refractive index material to increase the photonic effect. After repeating these RNIL
steps and stacking the 2D layers, a 3D structure was obtained. Haitainen et al. used T-NIL to
linearly pattern micro gratings on top of nano pre-patterned structures [85]. Then step and stamp
nanoimprint lithography (SSIL) was used to regulate the positioning and angle of the stamp
rotation.
Inclined nanoimprint lithography (INIL) is another technique used to develop 3D
nanostructures in a single-imprinting step without the need to use a 3D template or multiple
steps. In INIL, a polymer with an anisotropic dewetting phenomenon is used where the
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inclinatio
on angle con
ntrols the deg
gree of aniso
otropy. An IN
INIL apparattus induces a zero inclinnation
angle leaading to asym
mmetry in th
he polymer flow
fl path, re sulting in 3D
D nanopatterrns with diffferent
heights [156].
Despite recent progress in
n nanoimprin
nting and th e developm
ment of manyy new technniques
and comb
binations off techniques, overall, mo
ore research is needed too optimise thhe nanoimprrinted
3D moulds, substratees, and produ
ucts as cell culture
c
scafffolds. In sum
mmary, multii-layering off NIL
resists offfers many advantages;
a
however, th
he developm
ment of new instruments including m
multilayer alig
gners is requ
uired for such
h improvemeent.
•

Thrree dimensio
onal cell (3D
D) substrates provide connditions closer to the in vvivo environnment
and
d can be obtaained by eith
her direct nan
noimprint litthography ovver pre-patteerned resistss or
by vertical layeer-to-layer sttacking of reesists. Only vvery few repports in the liiterature are
avaailable so farr.

3.11. Concerns
C
Addressiing the con
ncerns assocciated with NIL is a sstep forwardd towards iits success. One
challengee is the tem
mplate wearr, which waas addresse d by Kumaar et al. Thhey showedd that
nanomou
ulding of thee template, performed
p
by
y metallic gllasses as amoorphous mettals can yield sub
100 nm patterns at a reduced cost of the template [1157]. Anothher solution presented w
was a
mable re-usaable templatte to reduce the cost of templates annd avoid tem
mplate wear [73].
programm
Another concern is that
t
NIL pro
ocesses rely
y on other liithographic techniques ssuch as elecctronhography orr focused ion
n beam pattterning to faabricate the mould withh high resoluution.
beam lith
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Howeverr some selff-assembled structures for
f templatees were esttablished byy NIL at a high
resolution
n of sub 10 nm
n scale [158].

Figure 3.5: Parameteers involved
d in the design of cell suubstrate. Fab
abrication asppects includde the
composittion of moulld, resist and
d substrate, size of nanosstructures, teexture, wettaability, rigidiity, as
well as the
t method used, etc. Fabrication
F
aspects
a
highhly influence the resoluution and coost of
method. Biological aspects
a
inclu
ude the cell ty
ype and its iinter-facial iinteraction w
with the subsstrate.
ven cells aree cultured on
n substrate, many other cell behaviioural factorrs are counteed in,
After giv
like celll growth co
onditions, cell
c
migratio
on, alignmeent, growth,, signaling, etc All those
parameteers are inter--connected, hence they should be aall considereed in the opptimisation oof the
design prrocess. Und
derstanding these param
meters can ddetermine w
which techniqque is best to be
used.
Here, we repo
ort on severaal approaches to use nnanoimprinteed scaffolds for cell cuulture.
Howeverr, the optim
misation of scaffolds forr cell and tiissue culturee involves nnot only thee NIL
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techniquee, resist, mo
ould and sub
bstrate, but also needs tto take into consideratioon the bioloogical
parameteers such as th
he cell type,, cell signallling, perfusi on, and manny other facttors involved. As
shown in
n Figure 3.5, a multitude of factors in
nterplays witth each otheer.
•

Opttimising NIL
L parameterss by reducing the templaate wear, cosst and increaasing the
reso
olution is neecessary for an
a effective technique.

3.12. Applications
A
s
Nanoimprint lithography is regularly
y applied inn the area oof nanofluiddics [159] w
which
studies the
t
complex
x fluid beh
haviour conffined to nannostructuress. A modifiied nano-im
mprint
techniquee was descriibed to deveelop nanoflu
uidic devicess with speciffic dimensioons [160, 161]. In
another approach,
a
the fabrication
n of an extreemely long ((1.5 cm) fluiidic channelss with sub-220 nm
diameter by nano-im
mprinting mo
ould fabricatiion is usefull in developiing biochem
mical sensorss with
162].
higher sensitivity [1

This report, however, highhlights seveeral studies in which nnano-

imprinted
d scaffold were
w
used in
n cell culturee and showeed to mimicc the naturall environmeent of
cells sign
nificantly bettter than a ceell culture flask.
•

Nanoimprint litho
ography (NIL
L) is applied
d in diverse aand broad reesearch fieldds, i.e. studyiing
cell reesponse to su
ubstrates, naanofludics, and
a biochem
mical sensors..

3.13. Conclusion
C
Nanoimprinting
g lithograph
hy representss a useful toool to imprintt 3D scaffoldds due to thee high
precision
n, well contrrollability an
nd unique fleexibility. Diifferent geom
metries withh a wide rannge of
polymerss including biodegradab
ble and bioccompatible polymers caan be modiified to meeet the
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needs of the fabricatiion process and
a the yield
ded scaffold.. It is certainn that the ressearch underttaken
so far to
t examine the effectts of substrate properrties on cell responses enhancedd our
comprehension. Cerrtainly, topo
ography affeected cell m
morphology, cytoskeletaal rearrangem
ment,
adhesion
n, differentiaation, prolifeeration and gene
g
expresssion. Not only the surfface featuress, but
also the cell type grreatly influeences the reesults. With this knowleedge in minnd, we can tailor
r
an
nd better imp
plement them
m to bio-mim
mic the natuural conditionns of cell cuulture.
cellular responses
There is, therefore, a definite need to disscover whicch substrate topographyy; each cell type
n. To attain a highly fu
unctional scaaffold, manyy fabricationn parameterrs are
favourably grows on
nt as revieweed here, whicch provides a wealth of ppossibilities. However aat this point, there
importan
is no up-front answerr to the quesstion of how to optimize topographiccal scaffoldss for cell culttures.
So far, a trial-and-errror approach
h has been followed, w
which intrinsiically limitss the outcom
mes to
what is achievable
a
in
nstead of whaat is desired.
•

Maany NIL tech
hniques existt, with variab
ble advantagges and disaddvantages too suit the useed
matterial, fabriccation steps and
a desired substrate.
s
Hyybridisation of techniques allows forr
more options.

3.14. Outlook
O
It becomes
b
ob
bvious that the applicattions for naanoimprintedd scaffolds are very bbroad.
Howeverr, also the ch
hoice of tech
hniques for nanoimprinti
n
ing and the vvariety of maaterials are vvastly
diverse. With this review,
r
we give an ov
verview of previous aand possiblee nanoimpriinting
techniquee as well as
a their adv
vantages and
d disadvanttages that ppartially posse limitationns on
combinattions of a technique
t
with
w
a certaiin material. New combbinations off techniquess and
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materials, however, may also develop as more research is performed. So far, applications are still
limited and very experimental, but an increase in model development, correlation of factors and
results for a better prediction of successful models, as well as a strong increase in publications
describing nanoimprinted cell and tissue culture models is expected.
We believe research in this field is advancing in two main directions. The first one would
be the optimisation of the polymer and scaffold properties. The second one could involve
integrating more ECM components into the cell culture conditions, i.e. proteins, lipids,
glucosamines, and others. Cells interact with ECM via transmembrane receptors called integrins
which link the ECM to molecular complexes that bind to actin filaments [163]. Interactions
mediated by integrins regulate cell adhesion, differentiation, migration and metastasis [164, 165].
Different integrins interact with different ECM ligands. The amino acid sequence RGD (ArgGly-Asp) is the main adhesive site in the fibronectin binding region [165-167]. Including
transmembrane ligands in cell culture substrates could augment our understanding of various
ligand-receptor interactions as described by Schvartzman et al. Their study showed that
spreading of mouse fibroblasts increased when at least four sites of ligands were placed within
60 nm or less with no dependency on density [168]. Similar studies with nanoimprinted
substrates including receptor proteins or ligands could give insights into interactions of cells with
different receptors. Besides, 3D models would be a step towards mimicking the natural
conditions of cell growth, but it is anticipated that research will move further towards a complete
organ scaffold model. One example could be a lung model, designed and manufactured by
nanoimprinting with detailed structures that can possibly be used in the future for transplantation
as well as a research model. So far, nanoimprinting has not been employed to fabricate such a
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model. However,
H
a sophisticated
s
d in vitro lu
ung tissue m
model on a m
microchip waas producedd by a
techniquee called miccrofabricatio
on to reconsstitute the hhuman-alveoolar capillaryy interface. This
device sh
howed simiilar structuraal, functionaal and mecchanical propperties to aalveolar cappillary
interface of human lung. It also showed sim
milar physiollogical effeccts to nanopaarticle absorrption
as in mo
ouse lung [169]. Such an approacch could po ssibly be foollowed by NIL techniiques.
Although
h a nanostru
uctured organ
n model is not
n yet feasible, we bellieve that thhis is the ultiimate
goal in the
t next yeaars. Develop
ping such macromodels
m
s with masssive complexity requirees the
consideraation of critiical concernss such as thee coordinatedd arrangemeent of differeent cell and ttissue
types in a particular architecturee, the vascularization off tissues, annd biosafety [171]. Therrefore
n
to haandle those complex
c
maccromodels [172]. Also, w
we expect thhat in
novel sollutions are needed
the futurre cell cultu
ure substratees will be further
f
cust omised baseed on the pproperties oof the
proposed
d cell line orr tissue, such
h as the morp
phology, riggidity, perfussion, and maany other facctors.
Examples are cortical bone tisssues with co
oncentric cyylindrical strructure, sponngy bone tiissues
with spon
ngy-like stru
ucture [173], skeletal muscles
m
with cylindrical muscle fibers, longitudiinally
aligned to
o each otherr [174], and cardiac
c
musccle cells withh a leaflet–liike morphollogy [175].
•

Nan
no-imprinted
d cell substraates hold greeat potential in diverse ffields. More work is needded
to optimise
o
and
d enrich these application
ns and to cusstomise the pproposed subbstrate.
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In this thesis, delivery systems for siRNA delivery are introduced with special attention to
non-viral vectors. Many successful vectors used in vivo were reviewed. Our work focused on the
effect of different architectures of oligospermine polmers on their suitability for siRNA delivery
in lung cancer cells. Different archituctures showed different polyplex structures and variable
transfection efficiencies. Moreover, we presented a review on nanoimprint lithography
techniques with an outlook on possible biological applications in the field of gene and drug
delivery.
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